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Abstract 
The protein arrestin is responsible for termination of GPCR signalling. In the rod cell, 
arrestin binds light-activated phosphorylated rhodopsin in order to block further signal 
transduction. The binding of arrestin to rhodopsin is a two-step process. Arrestin first 
interacts with the phosphorylated receptor C-terminus in a pre-complex, which induces 
conformational changes in arrestin that allow coupling to the helical core of the active 
receptor in a high-affinity complex. Biochemical studies and crystal structures have 
provided insights into the conformation of the arrestin-rhodopsin complex. This 
dissertation describes site-directed fluorescence experiments, which were carried out to 
further investigate the conformational changes occurring upon arrestin binding to 
rhodopsin. In particular this involved characterization of a previously unidentified 
association of arrestin with the membrane, as well as further elucidation of the structure 
of the pre-complex.   
The first section of this dissertation describes the association of arrestin with the 
membrane. Spin-labelled fatty acids, which spontaneously insert into the membrane and 
quench fluorescence, were used to determine the proximity of fluorescently-labelled 
sites on arrestin to different regions in the membrane. Loops on the C-edge of arrestin 
were found to penetrate the membrane. The C-edge anchor was only engaged after 
interaction with the phosphorylated receptor, demonstrating that it acts as a functional 
binding element, and interestingly the orientation and conformation was found to be 
different in the pre-complex as compared to the high-affinity complex.  
The second part of this dissertation describes intramolecular quenching analysis to 
monitor the orientation of the C-tail, and flexible loops on arrestin when bound in the 
pre-complex and the high-affinity complex. The presence of the negatively charged 
molecule IP6, and the inactive phosphorylated aporeceptor (OpsP) displaced just the 
distal portion of the C-tail. The proximal portion makes several contacts within the N-
domain of arrestin, with elements that stabilize the basal conformation of arrestin. 
Therefore, only when the proximal portion of the C-tail is released, which only occurs 
upon interaction with the active receptor, are the conformational changes associated 
with arrestin activation observed, including movement within the central crest loops, 
and interdomain rotation.  
The third part of this dissertation describes investigations of the stoichiometry of the 
arrestin – rhodopsin complex. Although the interaction of arrestin with a single receptor 
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has been shown to be functional, higher stoichiometries have also been observed. 
Titrations with fluorescently-labelled arrestin mutants bound to ROS membranes found 
that in conditions favouring pre-complex formation, arrestin binding in the high-affinity 
complex saturated at a one-to-one stoichiometry, as compared to in conditions which 
abrogated pre-complex formation, where the final stoichiometry of the high-affinity 
complex saturated at a one-to-two stoichiometry. As pre-complex formation was 
modulated by the addition of salt, the change in stoichiometry observed was not merely 
due to a lack of space on the membrane, and the pre-complex plays a role in conferring 
different binding modes in the arrestin-rhodopsin interaction. Interestingly the 
membrane anchor was also deployed in conditions favouring a one-to-two arrestin-
rhodopsin stoichiometry, thereby ruling out the previously proposed hypothesis that the 
C-edge could contact a second receptor in the high-affinity complex.   
Together the results presented in this dissertation further elucidate the nature of different 
binding modes of the arrestin-rhodopsin interaction. The conformation of arrestin in the 
pre-complex is indicated to resemble that of the basal state of arrestin, and involves two 
sites of contact: interaction with the phosphorylated receptor C-terminus, and 
association with the membrane. Upon transition to the high-affinity complex, arrestin 
undergoes a conformational change to a more active conformation: the C-tail is 
displaced, there is movement within the central flexible loops, and the orientation of the 
membrane anchor changes. The pre-complex therefore most likely functions to bring 
arrestin and the receptor into close contact, and in the correct orientation, to allow for 
fast transition to the high-affinity complex.  
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Abstract in German 
Die Aufgabe des Proteins Arrestin ist die Beendigung der Signalweitergabe über den 
GPCR Signalweg. In Stäbchenzellen bindet Arrestin an Licht-aktiviertes 
phosphoriliertes Rhodopsin um die Signalweitergabe zu unterdrücken. Die Bindung von 
Arrestin an Rhodopsin erfolgt in zwei Schritten. Zunächst wechselwirkt Arrestin mit 
dem phosphorilierten C-Terminus von Rhodopsin und bildet einen prä-Komplex, dies 
induziert Konformationsänderungen im Arrestin wodurch die Bildung eines High-
affinity Komplex unter Kopplung an den helikalen Kern des aktivierten Rezeptors 
erfolgen kann. Biochemische Untersuchungen und Kristallstrukturen haben einen 
Einblick in die Konformation des Komplexes aus Arrestin und Rhodopsin ermöglicht. 
In dieser Arbeit werden site-directed Fluorezenz Experimente angewandt um die 
strukturellen Änderungen zu untersuchen, die bei der Bindung von Arrestin an 
Rhodopsin ablaufen. Insbesondere wird hier eine, bisher nicht beschriebene, 
Assoziation von Arrestin an die Membran untersucht. Des Weiteren wurden 
Erkenntnisse über die Struktur des prä-Komplexes gewonnen.  
Der erste Teil dieser Arbeit befasst sich mit der Assoziation von Arrestin an die 
Membran. Spin-markierte Fettsäuren, die sich spontan in die Membran integrieren und 
Fluoreszenz löschen, wurden verwendet um die Annäherung fluoreszenzmarkierter 
Stellen des Arrestins an verschiedene Bereiche der Membran zu untersuchen. Es konnte 
gezeigt werden, dass die Schleifen an der C-Kante von Arrestin in die Membran 
eindringen. Der Membrananker im selben Bereich hat erst nach erfolgter Interaktion mit 
dem phosphorilierten Rezeptor in die Membran integriert. Hierbei fiel auf, dass sich 
Konformation und Orientierung des Ankers zwischen prä-Komplex und High-affinity 
Komplex unterscheiden. 
Der zweite Teil dieser Arbeit beschreibt die Orientierung des C-terminalen Endes sowie 
verschiedener flexibler Schleifen von Arrestin sowohl in dem prä-Komplex als auch 
dem High-affinity Komplex unter Verwendung von intramolekularer 
Fluoreszenzlöschung. In Anwesenheit von IP6, einem negativ geladenen Molekül, 
sowie dem inaktiven phosphorilierten Aporezeptor (OpsP) wird nur der distale Teil des 
C-Terminus von Arrestin verdrängt. Der proximale Teil hat an mehreren Stellen 
Kontakt mit der N-Domäne, in Bereichen, welche die basale Konformation stabilisieren. 
Wenn dieser proximale Teil sich bei Interaktion mit dem aktivierten Rezeptor löst gibt 
es Bewegungen innerhalb der Schleifen am zentralen Kamm und eine Rotation der 
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Domänen gegeneinander. Diese Änderung der Konformation ist mit der Aktivierung 
von Arrestin verknüpft. 
Im dritten Teil dieser Arbeit wird die Stöchiometrie des Arrestin-Rhodopsin-Komplexes 
untersucht. Es wurde gezeigt, dass ein einzelner Rezeptor mit Arrestin eine funktionale 
Einheit bilden kann, es gibt auch Untersuchungen bei denen eine höherer Stöchiometrie 
beobachtet wurde. Titrationen mit fluoreszenzmarkiertem Arrestin und ROS-
Membranen haben gezeigt, dass Arrestin unter Bedingungen, die die Bildung des prä-
Komplexes begünstigen, einen High-affinity Komplex im stöchiometrischen Verhältnis 
1 : 1 mit einem Rezeptormolekül bildet. Unter Bedingungen, die eine Ausbildung des 
prä-Komplexes verhindern, bilden Arrestin und Rezeptormoleküle einen High-affinity 
Komplex im stöchiometrischen Verhältnis 1:2. Es wird gezeigt, dass der Membrananker 
bei Bedingungen mit einer ein Arrestin zu zwei Rhodopsin Stöchiometrie ausgefahren 
ist; daher ist die bisherige Hypothese, dass der Kontakt zu dem zweiten Rezeptor über 
die C-Kante des Arrestins vermittelt wird, auszuschließen.         
In ihrer Gesamtheit ermöglichen die, in dieser Arbeit präsentierten, Ergebnisse ein tiefer 
gehendes Verständnis der unterschiedlichen Bindungsmodi innerhalb der 
Wechselwirkung zwischen Arrestin und Rhodopsin. Die Konformation vom Arrestin im 
prä-Komplex scheint die Konformation im Basalzustand nachzubilden unter 
Beteiligung zweier Kontaktstellen: Interaktion mit dem phosphorilierten C-Terminus 
des Rezeptors und Assoziation mit der Membran. Beim Übergang in den High-affinity 
Komplex durchläuft Arrestin eine Konformationsänderung in eine aktivere 
Konformation: der C-Terminus wird verdrängt, es erfolgt eine Neuausrichtung der 
zentralen flexiblen Schleifen und die Orientierung des Membranankers ändert sich. Die 
Aufgabe des prä-Komplexes ist somit Arrestin und den Rezeptor zusammen zu bringen 
sowie die korrekte Orientierung sicherzustellen um einen schnellen Übergang in den 
High-affinity Komplex zu ermöglichen.  
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1. Introduction 
 
1.1 G protein coupled receptors 
G protein coupled receptors (GPCRs) are a ubiquitously expressed class of membrane 
proteins. There are over 700 different types of receptors in the family, which all have the 
same general structure and activation mechanism (Lefkowitz 2004).  GPCRs interact with 
environmental and physiological ligands, including odorants, light, hormones and 
neurotransmitters, which can be activating (agonists) or deactivating (inverse agonists 
and antagonists). GPCRs are major drug targets, and almost half of currently marketed 
pharmaceuticals target a GPCR. Agonist binding results in conformational changes in the 
receptor, leading to G protein binding and activation, which then elicits further 
downstream effects in the cell (Pierce 2002). Phosphorylation of the receptor, and the 
subsequent binding of arrestin, results in termination of the signal (Gurevich and 
Gurevich 2004). 
 
1.2 Rhodopsin 
Rhodopsin is the GPCR present in retinal rod cells, which detects light at the single 
photon level. In its basal state rhodopsin is bound to its inverse agonist, 11-cis-retinal, via 
a protonated Schiff-base linkage to the protein. Light absorption isomerises 11-cis-retinal 
to the agonist all-trans-retinal (ATR), which induces activating conformational changes 
in the receptor. The binding partners of rhodopsin are the G protein transducin, the 
receptor kinase GRK1, and arrestin-1 (kühn 1980b, 1980a, 1978; Kuhn, Hall, and Wilden 
1984). The interaction between rhodopsin and arrestin-1 is the focus of this dissertation.   
 
1.2.1 The rod cell 
The rod cell is adapted for highly efficient detection of light and transduction of the signal. 
It is composed of an outer and inner segment, which are connected by a narrow cilium 
(Figure 1.1). The large outer segment is composed of hundreds of flattened membranous 
discs surrounded by a plasma membrane (Molday 1998). Half of the volume of the rod 
outer segment discs is composed of rhodopsin, and Atomic Force Microscopy (AFM) 
revealed that there were up to 50,000 rhodopsin molecules per µm2 in the rod outer 
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segment (Liang et al. 2003; Fotiadis et al. 2003), making up more than 80% of all proteins 
in this compartment (Daemen 1973). AFM and cryoelectron tomography studies suggest 
that rhodopsin molecules are highly organized within the disc membrane, arranged in 
ordered “track” structures, each containing two rows of rhodopsin dimers (Gunkel et al. 
2015; Liang et al. 2003).   
The smaller inner segment contains the nucleus, mitochondria, and other organelles and 
cellular machinery necessary to support cellular metabolism and protein synthesis, and 
leads to the synaptic terminal.  Arrestin and transducin translocate in opposite directions 
between the outer and inner segments depending on light intensity. In dim light arrestin 
is sequestered in the rod inner segment, whereas in bright light conditions, when there is 
a sufficient population of light-activated rhodopsin, it translocates to the rod outer 
segment (Broekhuyse et al. 1985). Transducin, on the other hand, moves towards the rod 
outer segment in dim light for activation by light-activated rhodopsin, and translocates to 
the inner segment in bright light to prevent excess signalling (Brann and Cohen 1987; 
Philp, Chang, and Long 1987).  
The retinal pigment epithelium (RPE) lies in close proximity to the rod outer segment and 
contains the enzymes involved in the retinoid cycle, which catalyses the conversion of 
all-trans-retinal (ATR) back to 11-cis-retinal. Briefly, ATR released from light-activated 
rhodopsin (Rh*) is reduced to all-trans-retinol, which is transported to the RPE. In the 
RPE a series of enzymatic reactions occur, where esterification of all-trans-retinol leads 
to the formation of retinyl esters, from which hydrolysis and isomerisation reactions form 
11-cis-retinol. Subsequent oxidation leads to 11-cis-retinal, which is released back into 
the rod outer segment for binding to rhodopsin (McBee et al. 2001; Kiser et al. 2012).   
 
 
 
 
Figure 1.1 Schematic of the rod cell  
The rod cell is composed of outer and inner segments: the rod outer segment contains 
rhodopsin and components of the visual signal transduction cascade. The rod inner segment 
contains the cellular organelles and machinery, and leads to the synaptic terminal. The tip of 
the rod cell is in close contact with cells of the retinal pigment epithelium, which contain 
enzymes responsible for the retinoid cycle that catalyse the conversion of all-trans-retinol back 
to 11-cis-retinal for regeneration of rhodopsin.   
RPE 
Rod Outer Segment 
Rod inner segment 
Synaptic terminal 
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1.2.2 Visual signal transduction 
Visual signal transduction (see figure 1.2) is a cycle involving activation (binding and 
activation of transducin), deactivation (receptor phosphorylation and arrestin binding), 
and recovery (dephosphorylation and regeneration of rhodopsin):  
1. Activation – The initial step occurs when rhodopsin absorbs a photon of light. A 
binding crevice opens on the cytoplasmic side of Rh*, where transducin binds. 
Transducin is a heterotrimeric G protein, consisting of an α, β and γ subunit. The 
α subunit has a guanine nucleotide binding site, which upon binding to active 
rhodopsin exchanges GDP for GTP. This step results in dissociation of transducin 
into two components: Gα-GTP, and βγ. Gα-GTP interacts with and activates the 
enzyme phosphodiesterase (PDE), which results in the hydrolysis of cGMP to 
GMP. Low cellular concentrations of cGMP lead to a change in permeability of 
cGMP-gated channels in the synaptic terminal, resulting in hyperpolarisation of 
the cell and an action potential (Leskov et al. 2000) (Arshavsky, Lamb, and Pugh 
2002). 
2. Deactivation – Rh* signalling is terminated in a two-step process. First, GRK1 
binds and phosphorylates Rh*, after which arrestin binds. As arrestin binds in the 
same cytoplasmic crevice as transducin, it occludes any further binding of 
transducin to the active receptor (Kuhn, Hall, and Wilden 1984; Wilden, Hall, and 
Kuhn 1986). The arrestin - rhodopsin interaction will be described in detail in 
section 1.4 
3. Recovery  –  Several minutes after light-activation of rhodopsin, the retinal Schiff 
base hydrolyses and all-trans-retinal leaves the ligand binding pocket of the 
receptor, resulting in the phosphorylated aporeceptor, opsin. The retinoid cycle 
converts all-trans-retinal back to 11-cis-retinal, which enters the retinal-binding 
pocket of opsin and reforms the Schiff base, thereby resulting in the regeneration 
of rhodopsin (Lamb and Pugh 2004; Philp, Chang, and Long 1987; Kiser, 
Golczak, and Palczewski 2014). After regeneration of rhodopsin and dissociation 
of arrestin, the receptor is dephosphorylated by the protein phosphatase 2A 
(PP2A) (Palczewski et al. 1989; Lee et al. 2010).  
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Figure 1.2 Schematic of signal transduction.  
After light-activation, rhodopsin (Rh*) binds and activates the G protein transducin, which 
dissociates and induces downstream effects resulting in hyperpolarisation of the cell. 
Deactivation of the system requires first phosphorylation of rhodopsin by rhodopsin kinase 
(GRK1), which allows for arrestin to bind. Release of all-trans-retinal (ATR), and 
dephosphorylation of the receptor by protein phosphatase 2A (PP2A), leads to arrestin 
dissociation. The resulting aporeceptor, opsin, exists in a conformational equilibrium between 
OpsP and Ops*P (see section 1.2.4 for more details). 11-cis-retinal re-enters the retinal binding 
pocket of Ops*, regenerating rhodopsin (Rho). Figure provided by Dr. Martha Sommer.   
 
 
1.2.3 Structure of Rhodopsin 
Rhodopsin consists of 348 amino acids, and is structured as 7 transmembrane helices 
connected by three extracellular loops and three cytoplasmic loops, as well as helix 8 
Downstream 
signaling leading to 
hyperpolarization of 
the cell 
11-cis-retinal 
all-trans-retinal 
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which lies parallel to the membrane on the cytosolic side. Rhodopsin is bound by its 
inverse agonist, 11-cis-retinal in its basal state, which is covalently linked to Lys296 
through a protonated Schiff base linkage. Upon light-activation, 11-cis-retinal isomerises 
to all-trans-retinal and the Schiff base deprotonates, resulting in protein structural 
changes and an active conformation (Hofmann et al. 2009; Palczewski et al. 2000).  
 
Figure 1.3 Structure of the retinoid ligands  
 
 
 
 
 
 
 
 
 
The basal structure of rhodopsin (shown in figure 1.4), is stabilised by two highly 
conserved motifs. The first is the E(D)RY motif on transmembrane helix 3 (TM3), which 
tethers TM3 and TM6 by forming an ionic lock. The second is the NPxxY(x)F motif on 
TM7 – Helix 8 (H8), which tethers TM7 and H8 and links TM7 to TM1 and TM2.  Upon 
light-activation these interactions are broken. In particular the breaking of the TM3-TM6 
ionic lock allows for movement of TM6, which undergoes an outward movement on the 
cytoplasmic side, opening a crevice which allows for binding of transducin and arrestin 
(Nygaard et al. 2009; Hofmann et al. 2009). 
The rhodopsin C-terminus contains seven phosphorylation sites: 3 serine and 4 threonine 
residues. At least three of these sites are required to be phosphorylated for high-affinity 
arrestin binding (Gurevich and Benovic 1993, 1995; Mendez et al. 2000). The arrestin 
binding site has been shown to involve interactions with residues on intracellular loop 2, 
which lies adjacent to the E(D)RY motif, as well as intracellular loop 3, which is located 
11-cis-retinal 
All-trans-retinal 
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near the cytosolic side of TM3 and TM5 (Raman, Osawa, and Weiss 1999; Shi et al. 1998; 
Krupnick et al. 1994; Krupnick, Gurevich, and Benovic 1997).  Additionally, intracellular 
loop 1, and the neighbouring TM7 and H8 have also been determined as an interaction 
site for loops on arrestin (Raman, Osawa, and Weiss 1999; Szczepek et al. 2014; Kang et 
al. 2015).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Structure of basal rhodopsin 
Helices are coloured: light blue =TM1, pale green = TM2, blue = TM3, pale yellow = TM4, 
light pink = TM5, brown = TM6, light orange = TM7, dark grey = H8. Sites involved in 
arrestin binding are shown in magenta, and are centred around intracellular loop (ICL) 1 near 
TM7-H8, lying adjacent to the conserved NPxxY(x)F motif, shown in cyan, and ICL2 and ICL3 
near TM5 and TM3, which lies adjacent to the conserved ERY motif, coloured in green.  The 
red spheres indicate the Cα of serine and threonine residues on the C-terminus which are 
phosphorylated by GRK1 for arrestin binding. Lys296, to which the retinal is covalently bound, 
is shown in yellow. PDB reference, 1U19. 
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1.2.4 Photo-activation cycle of rhodopsin  
The light-induced activation of rhodopsin occurs through a series of intermediate energy 
barriers (shown in figure 1.5). The first step after retinal isomerization results in the 
formation of Metarhodopsin-I (Meta-I), through spectroscopically distinguishable, short-
lived intermediates termed Batho and Lumi. Meta-I formation occurs on a fast, 
microsecond, timescale and corresponds to conformational changes localized to the 
retinal binding pocket. From Meta-I, a series of further sequential sub-states occur, termed 
Metarhodopsin-IIa, Metarhodopsin-IIb, and Metarhodopsin-IIbH*, which are 
spectroscopically identical, and exist in an equilibrium, which favours Metarhodopsin-
IIbH*. These sub-states correspond to more global changes in the conformation of the 
receptor. The initial sub-state (Metarhodopsin-IIa) corresponds to deprotonation of the 
Schiff base. Subsequent breakage of constraints that hold the receptor in its basal 
conformation, lead to the outward movement of TM6, which defines the second sub-state 
(Metarhodopsin-IIb). The final sub-state (Metarhodopsin-IIbH*) corresponds to the 
uptake of a proton to residue E134 on the conserved E(D)RY motif on TM3 (see figure 
1.4). It is this active conformation of the receptor that is able to bind transducin (Hofmann 
et al. 2009). An alternative pathway leads to the formation of Meta-III from Meta-I. To 
date, there is little known about the exact nature of this pathway, but the Meta-III 
conformation differs from Meta-II in that it has a reprotonated Schiff base that exists in 
the syn configuration, as opposed to the anti configuration that exists in the other Meta 
intermediates (Vogel et al. 2003).  
The decay of Meta-II occurs within minutes: the retinylidene Schiff base is hydrolysed 
and all-trans-retinal is released, leaving the aporeceptor opsin. This exists in an 
equilibrium between an inactive state (Ops), and a conformation more similar to the active 
receptor (Ops*). In the native membrane the conformational equilibrium is heavily shifted 
in favour of the inactive Ops (Vogel and Siebert 2001). However, the retinal ligands are 
only able to bind Ops*, through a retinal channel that is present in the active receptor 
conformation. The retinal channel is formed by the opening of two “holes”, through 
rearrangement of bulky residues between TM7 and TM1 (Hole A), and TM5 and TM6 
(Hole B), which connect the retinal binding pocket with the lipid bilayer (Hofmann et al. 
2006; Park et al. 2008; Scheerer et al. 2008). Binding of 11-cis-retinal stabilizes the 
inactive receptor conformation, and the two holes are snapped shut, thereby trapping the 
inverse agonist in the binding pocket until light-activation (Piechnick et al. 2012). All-
trans-retinal, on the other hand, enters and leaves in a fast equilibrium. Therefore 
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conditions which shift the conformational equilibrium of opsin towards Ops*, such as 
interaction with either transducin or arrestin, or activating mutations, allow for all-trans-
retinal to re-enter the ligand binding pocket (Sommer, Hofmann, and Heck 2012; 
Jastrzebska et al. 2013; Schafer et al. 2016). 
 
Figure 1.5 Photo-activation cycle of rhodopsin. 
After absorption of a photon of light, rhodopsin is activated through a series of intermediates to 
metarhodopsin II, which binds and activates transducin, and binds arrestin. Exit of the agonist 
all-trans-retinal, and rebinding of the inverse agonist 11-cis-retinal regenerates rhodopsin. See 
main text for details.  
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1.3 Arrestin 
The arrestin family is comprised of just four different variants which all share the same 
basic structure. Arrestin-1 and arrestin-4 are expressed in rod and cone cells, respectively, 
and regulate the visual opsins.  Arrestin-2 and arrestin-3, also called β-arrestin-1 and β-
arrestin-2, are ubiquitously expressed and interact with hundreds of different GPCRs 
(Lohse and Hoffmann 2014). The β-arrestins are conformationally flexible in order to 
confer the necessary receptor-binding promiscuity. The main function of arrestin is to 
block G protein binding and thereby terminate G protein-mediated signalling. However, 
the β-arrestins also mediate their own signalling by binding to other signalling molecules 
including transcription factors, signalling kinases and phosphatases. The β-arrestins 
additionally mediate receptor internalization and trafficking by binding components of 
the cellular internalization machinery such as clathrin and AP2 (Xiao et al. 2007; Lohse 
and Hofmann 2015; Reiter et al. 2012).  
 
1.3.1 Arrestin-1 
The first crystal structure of native bovine arrestin-1 obtained from rod outer segments 
was solved in 1998 (Granzin et al. 1998). A higher resolution structure of recombinant 
arrestin-1 was published soon after (Hirsch et al. 1999).  Arrestin-1 crystallized in a 
tetrameric form, with 2 monomers displaying an “open” conformation, and 2 monomers 
displaying a “closed” conformation. The differences between these conformations are 
localized to flexible loops that form the oligomerization interfaces, namely the finger 
loop, the 160-loop, and the 344-loop (figure 1.6). Arrestin self-associates in a 
concentration-dependent manner, with tetramers and dimers forming at higher 
concentrations, and the monomeric form prevalent at lower concentrations (Vishnivetskiy 
et al. 1999; Imamoto et al. 2003; Hanson et al. 2007). Interestingly, the tetramer that forms 
in solution differs from the crystallographic tetramer (Hanson et al. 2007; Hanson et al. 
2008). The physiologically relevant tetramer is believed to associate with microtubules 
in the inner segment when arrestin is sequestered there in dim light conditions (Hanson 
et al. 2007). Translocation of arrestin to the outer segment in bright light conditions 
lowers the concentration, which promotes dissolution of the oligomer. This phenomenon 
favours receptor binding, as key-receptor binding elements are occluded within the 
oligomerization interface, and only the monomer can interact with the receptor (Hanson 
et al. 2008).   
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The basic structure of arrestin consists of two near-symmetric cup-like domains placed 
end-to-end, called the N- and C-domain. Each domain is composed of a 4 stranded β-
sheet packed upon a 3 stranded β-sheet. Additionally there is a small α-helix in the N-
domain, and the C-domain is connected via a linker region to the long flexible C-tail. This 
C-tail interacts extensively with the N-domain, although the distal portion remains 
unresolved in the crystal structure (Granzin et al. 1998) (Hirsch et al. 1999; Vishnivetskiy 
et al. 1999).  
Figure 1.6 Structure of visual arrestin-1 
The N-domain is coloured in light grey, and the C-domain in dark grey. The dashed line 
indicates a portion of the C terminus that remains unresolved in the crystal structure. Regions 
important in the stabilization of arrestin, or involved in the arrestin – receptor complex are 
labelled, and discussed below (PDB reference: 1CF1, α monomer). 
 
Description of important regions in arrestin 
The labelled loops in figure 1.6 are described below. These regions of arrestin are 
involved either in the stabilization of basal arrestin, or at the binding interface of the 
arrestin-rhodopsin complex. The activation of arrestin and the structure of the complex 
will be explained in more detail in the following sections.  
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The C-tail, shown in green, is comprised of the terminal 32 residues on arrestin-1: 372-
404. It is flexible, and unstructured, with the distal portion remaining unresolved in crystal 
structures. It is connected by a flexible linker to the C-domain, and it interacts at several 
sites on the N-domain, including the polar core and three element interaction (Hirsch et 
al. 1999). The C-tail acts as an auto-regulatory element, which constrains arrestin in a 
basal conformation, and is displaced upon interaction with the receptor (Smith et al. 1994; 
Pulvermüller et al. 1997).  
The polar core, shown in red, is a cluster of charged residues buried between the N- and 
C- domain, including residues D30, R175, K176, D296, D303 and R382. Of these 
residues R382 is on the C-tail, and sites D303 and D296 are on the gate loop (296-305), 
shown in cyan. The cluster is stabilised by salt bridges, as shown in figure 1.7, which 
stabilise the basal conformation of arrestin. Displacement of the C-tail results in 
disruption of the polar core, and movement of the gate loop (Hirsch et al. 1999; Kim et 
al. 2013; Shukla et al. 2013).  
The three element interaction, shown in blue, is a hydrophobic interaction between 
residues on β-strand-I (9-14) and α-helix-I (103-111) on the N-domain, and β-strand-XX 
(373-380) on the C-tail (shown in green), see figure 1.7. Along with the polar core, this 
interaction helps to stabilise the inactive arrestin conformation (Hirsch et al. 1999; 
Vishnivetskiy et al. 1999).   
The Finger loop, shown in dark pink, is comprised of residues 68-77. It is a flexible loop 
which is folded down in the β-conformer of the arrestin structure, and extended in the α-
conformer (Hirsch et al. 1999). Numerous studies have highlighted this loop as an 
interaction site with the active receptor (Sommer, Hofmann, and Heck 2012; Hanson et 
al. 2006; Szczepek et al. 2014; Kang et al. 2015).  
Central crest loops, include the finger loop, described above, as well as the C-loop 
(residues 247-255) and the middle loop (133-142), shown in gold, and the 17-18 loop 
(residues 287-317), shown in magenta, which also includes the gate loop, described 
above, which is shown in cyan. These loops lie at the interdomain interface and form 
several interactions between the two domains in the basal arrestin conformation. Upon 
arrestin activation, they undergo a reorientation, and interact with sites on the active 
receptor in the complex (Kim et al. 2013; Shukla et al. 2013).  
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The C-edge loops, are shown in purple, and consist of the 344-loop (residues 338-346) 
and the 197-loop (residues 196-201). They are on the distal C-edge of arrestin, and results 
presented in section 3.1 of this dissertation describe their interaction with the membrane 
upon arrestin binding to rhodopsin.  
The 160-loop, shown in orange, consists of residues 159-163. These residues are on the 
distal N-edge of arrestin. The flexible loop contains many charged residues, with three 
acidic residues (E160, E161, and D162) lying adjacent to the basic K163 residue. This 
loop has been suggested as a putative site of interaction with rhodopsin (Shukla et al. 
2014; Kang et al. 2015).  
 
1.3.2 Activation mechanism of arrestin 
1.3.2.1 Initial model of arrestin activation 
Early insights into the activation mechanism of arrestin proposed that it was a two-step 
process, requiring both a phosphorylation and an activation sensor. Arrestin binding was 
found to be highly specific for the active phosphorylated receptor (Rh*P), with a lower 
level of binding observed with both the unphosphorylated active receptor (Rh*) and the 
phosphorylated inactive receptor (RhP), and virtually no binding to the inactive non-
Figure 1.7 The polar core and the three element interaction  
a) the polar core. Residues from the N-domain are shown in red, from the C-tail in green, and the 
gate loop in cyan. Stabilising salt bridges between the negatively and positively charged amino 
acids comprising the polar core are shown as black dashes. b) The three element interaction: 
Hydrophobic interactions are formed between the N-domain: α-helix -I and β-sheet-I, shown in 
blue, and the C-tail shown in green.  
a) 
Arg 382 
Asp 303 
Asp 296 
Asp 30 
Arg 175 
b) 
Phe 366 Phe 4 
Val 2 
Leu 111 
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phosphorylated receptor (Rh) (Kuhn, Hall, and Wilden 1984; Gurevich and Benovic 
1993).  
Initial experiments identified three regions which were involved in arrestin activation: 
1. The first region identified was the C-tail. Truncation of the terminal 37 residues 
of arrestin, and the subsequent discovery of p44, a natural splice variant of arrestin 
lacking the C-tail (Smith et al. 1994), displayed phosphorylation independent 
binding to the receptor. Further proteolysis experiments found that in the presence 
of the phosphorylated receptor C-terminus, the C-tail of arrestin was displaced. 
Moreover, this effect could be mirrored by the presence of IP6, which contains 
several phosphate groups, or heparin, a large polyanion molecule, thereby 
suggesting a large negative charge would lead to C-tail displacement (Palczewski, 
Buczylko, et al. 1991) (Gurevich et al. 1994; Zhuang et al. 2010). This provided 
initial evidence to support the idea that the C-tail of arrestin acted as an 
autoinhibitory structure. 
2. The second region which resulted in a loss of binding specificity when mutated 
was the polar core, in particular the salt bridge between R175 – D296 (see figure 
1.7) (Vishnivetskiy et al. 1999). Mutations that neutralised or reversed the charge 
of either of these residues resulted in increased binding to Rh* and Rh*P, as 
compared to wild type arrestin, whereas a charge reversal of both sites, which 
retained the salt bridge, restored the binding specificity (Gurevich and Benovic 
1995) (Gurevich and Benovic 1997; Raman et al. 2003). 
3. The third region identified was the three element interaction. Mutations which 
removed the hydrophobic residues involved in the interaction, resulted in 
increased binding to RhP and Rh*. Lying adjacent to β-strand-1 in the three 
element interaction, are two lysine residues, K14 and K15. Charge reversal 
mutations of these residues led to a dramatically decreased binding to Rh*P and 
RhP, leading to the proposal that they act as the initial phosphate sensor 
(Vishnivetskiy et al. 2000).  
Further mutagenesis studies showed that shortening the hinge region between the two 
domains abrogated binding, but substitution of individual residues had no effect 
(Vishnivetskiy et al. 2002). This, combined with the large diameter of arrestin as 
compared to the cytoplasmic side of rhodopsin, and the high energy barrier of interaction 
(Schleicher, Kühn, and Hofmann 1989), led to the proposal that C-tail displacement and 
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subsequent disruption of the polar core and three element interaction led to a large-scale 
conformational change. The two domains were thought to move relative to each other in 
a “clam-shell” movement, bringing the edge of both domains into contact with the 
cytoplasmic side of the receptor.  
   
1.3.2.2 Recent perspectives on the arrestin activation mechanism 
Various experimental techniques have been utilised in order to follow the conformational 
changes occurring in arrestin upon binding to rhodopsin, and have repudiated the idea of 
the large clam-shell movement of arrestin. Double electron-electron resonance (DEER) 
experiments, which measured intramolecular distances of doubly spin-labelled arrestin 
mutants in the unbound and Rh*P-bound states, found no evidence to support the large 
scale movement of the two domains relative to each other (Kim et al. 2012). Instead 
smaller movement was seen to be localised to some loops on arrestin, namely the finger 
loop and the middle loop, as well as to a smaller extent on the distal edges of arrestin: the 
160-loop and 344-loop. Similarly FTIR experiments detected no large scale changes in 
the conformational structure of arrestin upon binding to Rh*P, although a loss in β-sheet 
structure suggested that binding was correlated with an increased flexibility in the arrestin 
structure (Beyriere et al. 2015). Therefore, the initial hypothesis of arrestin activation had 
to be modified.  
Further insights into the conformational changes occurring in the arrestin structure upon 
activation came from the crystallisation of pre-active arrestin p44, which lacks the 
terminal 35 residues constituting the arrestin C-tail (Kim et al. 2013) and the structure of 
active arrestin-2 bound to a peptide analogue of the vasopressin phosphorylated receptor 
C-terminus (V2Rpp) (Shukla et al. 2013). 
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1.3.2.3 Conformational changes associated with arrestin activation 
 
Figure 1.8 Structure of basal arrestin and p44 
Left: Basal arrestin, PDB code: 1CF1, α conformer. Right: p44, PDB code: 4J2Q. The C-tail 
present only in the basal arrestin structure is shown in green. Loops which undergo 
conformational changes between the two structures are coloured: cyan = gate loop, orange = 
17/18 loop, yellow = middle loop, violet = C loop, and the polar core is shown in red. The 21° 
interdomain rotation that is observed in the p44 structure is indicated.  
 
The structures both obtained similar results for the orientation of loops in the active 
arrestin structure. The loops undergoing rearrangements as compared to the basal 
structure of arrestin are described below.  
Displacement of the C-tail and movement of the gate loop 
In the structure of arrestin – V2Rpp the C-tail was displaced and this resulted in disruption 
of the polar core and the three element interaction, which was also observed in the p44 
structure which lacks the C-tail.  The gate loop, containing the residues D296 and D302 
which comprise part of the polar core, was observed to move towards the N-domain as 
compared to the basal structure of arrestin, and this movement resulted in an exposed cleft 
of positively charged residues (K14, K15, K171, K175 and K300), which act as a 
potential binding site for the phosphorylated receptor C-terminus (Kim et al. 2013). 
Indeed, the phosphorylated residues on V2Rpp were shown to contact the residues on 
arrestin-2 equivalent to K14 and K15 on the concave surface of the N-domain (Shukla et 
al. 2013). The movement of the gate loop seen in the p44 structure was confirmed with 
fluorescence quenching experiments with arrestin bound to the active phosphorylated 
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receptor Rh*P (Kim et al. 2013). A fluorophore at site I299 on the gate loop was quenched 
by a tryptophan substituted at site L173 in the N-domain when arrestin was bound to 
Rh*P but not in the unbound state. These observations confirm that the two sites are 
distant in basal arrestin and become close upon arrestin activation, and are consistent with 
the gate loop movement seen in both structures.  
Extension of the finger loop and movement of the central crest loops 
Both structures also suggested that the finger loop was extended in the active arrestin 
structure (Kim et al. 2013; Shukla et al. 2013). Fluorescence studies which indicated that 
this loop enters into a hydrophobic environment (Sommer, Smith, and Farrens 2005), and 
Electron Paramagnetic Resonance (EPR) studies which showed that it becomes 
immobilised (Hanson et al. 2006) upon interaction with Rh*P, suggest that the extension 
of the loop observed allows for binding to the active receptor. Furthermore, the β-sheet 
at the base of the finger loop is extended in the p44 conformation as compared to basal 
arrestin, which could serve to stabilise the interaction between the finger loop and the 
active receptor.  The 17-18 loop winds around the two β-sandwiches of the N- and C- 
domains of arrestin, and is involved in stabilising the interdomain interface in basal 
arrestin. In the p44 structure, movement of this loop disrupts several interactions at the 
interdomain interface, which results in the 21° rotation of the two domains relative to 
each other. In particular the hydrogen bond network YKS(N)D(A) connecting the finger 
loop, middle loop and C-loop in basal arrestin is disrupted. A short β-strand forms 
adjacent to the 17-18 loop, which forms a new hydrogen bond network, TMQGL, with the 
middle loop (which moves closer to the finger loop) and the base of the finger loop. This 
new hydrogen bond network helps to stabilise the finger loop in its extended 
conformation. The C-loop, on the other hand, moves towards the C-domain, away from 
the finger loop, to allow space for binding to the receptor (Kim et al. 2013) (see figure 
1.9). 
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1.4 Structure of the arrestin – rhodopsin complex 
The finger loop of arrestin was suggested as a putative binding site in the arrestin-
rhodopsin complex, due to the conformational rearrangement which resulted in the loop 
adopting an extended conformation in activated arrestin (Kim et al. 2013; Shukla et al. 
2013), as well as its sequence similarity to the binding site of the Gα-subunit of 
transducin. A peptide of the finger loop was co-crystallised with Ops* and the resulting 
structure showed that it could bind in the crevice adjacent to the ERY motif on the 
cytoplasmic side of the receptor, and made additional contacts to the TM7-H8 helical 
bundle (Szczepek et al. 2014).  The loop was observed to adopt a reverse-turn structure 
upon binding to the receptor.   
Further insights into the nature of the complex came from an Electron Microscopy (EM) 
structure (Shukla et al. 2014). The structure obtained was of a mutated β2-Adrenergic 
Basal arrestin p44 
Figure 1.9 Hydrogen bond networks within the central crest loops 
 left: basal arrestin (1CF1, chain a) and right: p44 (4J2Q, chain a) 
green: 17-18 loop, orange: middle loop, pink: C loop, blue: finger loop. Side chains 
comprising the H network are shown in red. In basal arrestin this network is YKS(N)D(A). 
In p44, this network is broken, and a new H-bond network forms, which is T(M)QGL. 
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receptor (β2AR), in complex with β-arrestin 1, along with a FAB30 antibody to stabilise 
the complex. Negative EM staining revealed two conformations of arrestin. The first 
involved interaction of arrestin with the helical core of the receptor, whereas the second 
conformation showed arrestin “hanging off” from the receptor, at a 90° angle to the 
membrane, in an interaction with the edge of one of the arrestin-domains. This suggested 
that binding of arrestin to the receptor is flexible, and there are possibly different binding 
modes of interaction. Hydrogen-Deuterium exchange (HDX) was carried out in order to 
confirm the visualisation of interacting loops on arrestin with the receptor, and 
demonstrated that the finger loop, middle loop, and C loop were all in a more buried 
environment upon complex formation.  
 
1.4.1 Crystal structure of the complex 
The most detailed perspective of arrestin binding to rhodopsin came from the crystal 
structure of the complex (Kang et al. 2015). The structure was derived from a 
constitutively active mutant opsin fused via a 15-amino acid linker to a constitutively 
active mutant arrestin. Crystallization was facilitated by fusion of T4 lysozyme to the 
N-terminus of opsin. 
The crystal structure of the Ops*/arrestin-1 fusion complex identified four main areas at 
the arrestin-receptor interaction interface.  
1. The finger loop on arrestin, which had been previously identified as involved in 
binding to the active receptor (Sommer, Smith, and Farrens 2005; Hanson et al. 
2006) (Szczepek et al. 2014) was confirmed to interact with the cytoplasmic side 
of TM7, H8 and ICL1. The cytoplasmic face of the helices is positively charged, 
whereas the finger loop contains three negatively charged residues: (E70, D71 and 
D73). Therefore, the interaction is stabilised not only by shape, but by electrostatic 
interaction. Interestingly, the loop adopted an alpha helical conformation, as 
opposed to the reverse-turn structure observed in structure of the finger loop 
peptide (Szczepek et al. 2014). This could be attributed to differences between 
peptide and protein binding, or an artefact of activating mutations introduced into 
arrestin and rhodopsin in the ops*/arrestin-1 fusion complex. However, it could 
also be as a result of flexibility in the finger loop, resulting in different binding 
orientations.  
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2. The second interaction site was found to involve the central crest loops of arrestin. 
The middle loop and C-loop are in close contact in the basal structure of arrestin, 
but upon activation of arrestin move away from each other (Kim et al. 2013; 
Shukla et al. 2013). This results in a crevice forming between the two loops, which 
is able to accommodate ICL2 of rhodopsin, which adopts an α-helical 
conformation upon interaction. The nearby 17-18 loop on arrestin also forms 
contacts with the cytoplasmic side of TM5, which lies adjacent to ICL2.  
3. The third interaction site was with the β-strand which forms at the base of the 
finger loop, containing residues 79-86. In the crystal structure this is observed to 
interact with TM5, TM6 and ICL3. The 160-loop on the N-edge was also found 
to make contacts with the cytoplasmic face of TM6. 
4. The final interaction site was between residues 11-18 on the N-terminal edge of 
arrestin and the C-terminus of the receptor. This was not resolved in the crystal 
structure, and therefore the interaction was not directly observed. However, 
modelling studies and DEER experiments, as well as the orientation of arrestin 
with the receptor in the complex, led to this region being proposed by Kang et al 
as a final binding interface between arrestin and rhodopsin.   
The identification of interfaces of interaction observed in the ops*/arrestin-1 fusion 
complex crystal structure were supported by biochemical studies. Mutations introduced 
into the finger loop and central crest loops reduced arrestin binding to the active 
rhodopsin, and cross-linking experiments between arrestin and active rhodopsin also 
supported the close contact of residues at each of the identified interaction sites. Moreover 
HDX exchange experiments, which were shown to occur at a slower rate in complexed 
arrestin as compared to basal arrestin, indicated that the arrestin structure is stabilised by 
complex formation. In particular, the shielding of the finger loop from HDX exchange in 
the complex confirmed burial of this loop in the interaction, a result also previously 
observed with fluorescence and EPR studies (Sommer, Smith, and Farrens 2005; Hanson 
et al. 2006).  
The complex obtained showed asymmetric binding of arrestin to the active receptor, with 
the C-domain of arrestin orientated in a manner that suggests interaction with the 
membrane. There was no membrane present in the structure, and the distal C-edge of 
arrestin was not fully resolved in the structure, and therefore this could not be confirmed. 
However, the C-edge of arrestin contains a cluster of hydrophobic residues, which have 
been shown to dramatically reduce binding to active rhodopsin upon mutation to alanine 
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(Ostermaier et al. 2014). Furthermore, fluorescence labels at site 344 on the C-edge of 
arrestin show that the site moves into a hydrophobic environment, in a concentration-
dependent manner, upon interaction of arrestin with the receptor (Sommer, Hofmann, and 
Heck 2012). This possibility, and the nature of an interaction between the C-edge of 
arrestin and the membrane, will be explored further in this dissertation. 
 
 
Figure 1.10 Structure of the ops*/arrestin-1 fusion complex 
Rhodopsin is shown in light green, and arrestin in shown in yellow. Main interaction sites 
are with the arrestin finger loop (shown in blue), and the arrestin middle and C-loop 
(shown in magenta), and the β-sheet at the base of the finger loop (shown in light blue). 
The distal N-edge of arrestin, which was proposed to interact with the unresolved 
receptor C-terminus is shown in cyan. PDB code: 4ZWJ.   
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1.5 Binding modes of arrestin 
The crystal structure of the arrestin-1/ops* complex has provided insight into one binding 
mode of arrestin with active opsin. However, this does not rule out the possibility of 
further binding modes. The negative stain EM structure obtained (Shukla et al. 2014) 
contained two visualisations of the arrestin-receptor complex. In one structure arrestin is 
interacting with the helical core of the receptor, and could correspond to the high-affinity 
complex. However, in the second structure arrestin is contacting the receptor through one 
of its edges, lying at a 90° angle to the membrane. This could reflect a different binding 
mode of the complex, and could be a representation of the pre-complex, as described 
below. 
1.5.1 The pre-complex 
As well as binding the light-activated phosphorylated receptor (Rh*P), arrestin is also 
able to interact with the inactive phosphorylated receptor (RhP) in a lower affinity 
interaction, characterised by a Kd of 80µM in 100mM NaCl (Zhuang et al. 2013), and a 
Kd of around 1µM in the absence of salt (Sommer, Hofmann and Heck 2012). This 
interaction between arrestin and the phosphorylated receptor C-terminus, is thought to 
represent an intermediate step in arrestin binding to Rh*P (see scheme 1). Arrestin 
binding to Rh*P was initially proposed to be a two-step process through the determination 
of kinetic binding constants of both arrestin and p44 binding to Rh*P. As p44 is in an 
active conformation, it was pre-complexed in the dark to RhP, whereas arrestin remained 
unbound. Upon light-activation, the rate of p44 binding was faster than that of arrestin, 
and was concentration independent. The authors therefore proposed that binding of 
arrestin to Rh*P involved an initial first step, which brought the proteins into contact 
through the phosphorylated receptor C-terminus, and primed arrestin for the second 
binding step, which involved a conformational rearrangement resulting in tight binding 
(Schröder, Pulvermüller, and Hofmann 2002).  
  
RhP + Arr        [Rh*P ~ Arr]pre-complex                          [R*P – Arr]high-affinity complex 
Scheme 1  
Arrestin binding to rhodopsin is a two-step process. First arrestin engages the phosphorylated 
receptor C terminus in a pre-complex interaction, before transition to high-affinity binding.  
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To date little is known about the structure of the pre-complex. Proteolysis (Palczewski, 
Pulvermüller, et al. 1991; Palczewski, Buczylko, et al. 1991) and nuclear magnetic 
resonance (NMR) (Zhuang et al. 2013) experiments have determined that interaction 
between arrestin and the phosphorylated receptor C-terminus results in flexibility in the 
C-tail region of arrestin. The interaction was also found to display much higher sensitivity 
to salt than the high-affinity complex, implying that the interaction is mainly electrostatic 
(Gurevich and Benovic 1993; Sommer, Hofmann, and Heck 2012). Studies comparing 
sites on arrestin in the presence of RhP and Rh*P determined that the conformation of 
arrestin in the pre-complex is distinct from that in the high-affinity complex. Fluorescence 
experiments indicated that the finger loop, the C-edge loops and the C-loop are all 
orientated in different environments in the pre-complex as compared to the high-affinity 
complex, as fluorophores attached at sites on these loops all demonstrate an increase in 
fluorescence upon binding to Rh*P as compared to RhP (Sommer, Hofmann, and Heck 
2012). Additionally, EPR experiments found that the central crest loops and C-edge 
loops, as well as sites on the concave surface of the N-domain, demonstrated a decreased 
mobility in the pre-complex as compared to basal arrestin (Hanson et al. 2006). Upon 
light-activation, there was a further change in mobility in the central crest loops, with the 
middle loop becoming more mobile, and the finger loop almost immobilized. These 
studies highlight that the structure of arrestin in the pre-complex and the high-affinity 
complex are different. However, the orientation of these loops in the pre-complex remain 
to be elucidated, and will be further investigated in this dissertation.  
 
1.5.2 Stoichiometry of the complex 
The crystal structure of the ops*/arrestin-1 fusion complex showed one arrestin bound to 
one receptor (Kang et al. 2015). This stoichiometry has been determined to be functional, 
as binding assays carried out with monomeric rhodopsin reconstituted into nanodiscs, 
found that arrestin was able to bind with a similar affinity as to native membranes 
(Bayburt et al. 2011). Furthermore, arrestin binding and stabilisation of the active receptor 
state, metarhodopsin II, was also found to saturate at a one-to-one stoichiometry of 
arrestin to receptor (Pulvermüller et al. 1997; Schleicher, Kühn, and Hofmann 1989).  
However other binding stoichiometries cannot be ruled out. The idea of a one-to-two 
stoichiometry was initially proposed due to the large diameter of arrestin as compared to 
rhodopsin (Modzelewska et al. 2006). Initial evidence for a one-to-two binding 
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stoichiometry came from arrestin binding studies with ROS membranes containing 
different proportions of light-activated receptors. The study observed that at higher photo-
activation densities overall binding stoichiometry plateaued at one arrestin per two 
receptors, as compared to at lower photo-activation densities, where the binding 
stoichiometry plateaued at one-to-one (Sommer, Hofmann, and Heck 2011). Further 
experiments monitored fluorescence changes occurring at sites on the finger loop and the 
344-loop, in combination with centrifugal pull-down assays which determined the 
amount of arrestin bound. The fluorophore on the finger loop reported the amount of 
arrestin bound to Rh*P, but showed minimal fluorescence change in the presence of the 
aporeceptor even though arrestin was bound. However, the fluorescence changes 
occurring with the fluorophore on the 344-loop reported the amount of arrestin bound to 
both Rh*P and the aporeceptor. Therefore, a model was proposed that suggested the 
finger loop of arrestin always interacted with the active receptor crevice in a high affinity 
interaction. However, the 344-loop of arrestin was more flexible, interacting either with 
the membrane, in the case of a one-to-one binding stoichiometry, or contacting a 
neighbouring receptor in a low affinity interaction, in the case of a one-to-two binding 
stoichiometry (Sommer, Hofmann, and Heck 2012). The validity of the model will be 
investigated in this dissertation, along with factors influencing the final stoichiometry of 
the high-affinity complex.    
 
1.6 Aims of the project  
This dissertation further elucidates the interaction between arrestin and rhodopsin. The 
crystal structure obtained of the ops*/arrestin-1 fusion complex (Kang et al. 2015) 
provided clear insights into the nature of the complex, but left some unresolved questions. 
The structure obtained was in the absence of membrane, and the C-edge loops of arrestin 
were unresolved. However, the orientation of arrestin in the complex indicated that an 
interaction between the C-domain of arrestin and the membrane was possible. This 
dissertation addresses this possibility using site-directed fluorescence in combination 
with spin-labelled fatty acids which spontaneously insert into the membrane. As the spin 
labels quench fluorescence, the proximity between fluorophores individually attached to 
different sites on arrestin and different regions of the membrane are able to be monitored, 
and a binding interaction between arrestin and the membrane can be characterized.  
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Moreover, even though the ops*/arrestin-1 fusion complex structure fits well to 
biochemical studies, which proposed the finger loop was involved in the arrestin-
rhodopsin binding interface (Szczepek et al. 2014), and that no large-scale conformational 
rearrangement occurred upon formation of the complex (Beyriere et al. 2015; Kim et al. 
2012), there is evidence to suggest that other binding modes are possible. Arrestin 
interacts initially with the phosphorylated receptor C-terminus, in an interaction termed 
the pre-complex, before transition to tight binding in the high-affinity complex (Schröder, 
Pulvermüller, and Hofmann 2002). However, there is little information about the structure 
of this complex. This dissertation presents new insights into the structure of the pre-
complex as compared to the high-affinity complex, using intramolecular quenching, 
which monitors conformational changes occurring in arrestin upon interaction with the 
different receptor species. The implications of pre-complex formation on the final binding 
stoichiometry will also be addressed. Through modulating the pre-complex interaction 
using salt, and observing the effect on the stoichiometry of the complex, it can be 
determined whether there is a link between pre-complex formation and the final binding 
stoichiometry of the high-affinity complex observed after light-activation (Sommer, 
Hofmann, and Heck 2011, 2012).  
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2. Methods and Techniques 
2.1 Fluorescence Spectroscopy 
Site directed fluorescence spectroscopy is a useful tool for observing intramolecular 
conformational changes occurring in proteins, and interactions of proteins with binding 
partners (e.g. ligands, peptides, proteins and membranes). Experiments reported in this 
dissertation utilised this technique to monitor arrestin-rhodopsin interactions, and to 
follow the conformational changes occurring in arrestin between the basal and bound 
conformations. The technique involved substituting a single site in arrestin with cysteine 
and then modifying that cysteine with a sulfhydryl-reactive fluorophore, either 
monobromobimane, or N,N’-Diemthyl-N-(Iodoacetyl)-N’-(7-Nitrobenz-2-Oxa-1,3-
Diazol-4-yl)Ethylenediamine) (NBD) (purchased from Invitrogen), shown in figure 2.1. 
Specificity of labelling was ensured by first removing all native reactive cysteines from 
arrestin (C63A, C128A, C143A). As these fluorophores are small (<1 kilodalton) they do 
not significantly affect the structure of arrestin, when placed at a surface exposed site. 
Moreover, the fluorophores chosen are solvent sensitive, which means their spectra 
characteristics (lifetime, intensity, and wavelength of emission) are dependent on the 
relative polarity of their environment, and therefore are able to provide information about 
structural changes occurring at the site to which they are attached.  
Figure 2.1 Fluorophores used for arrestin-labelling 
 
 
 
 
 
 
 
 
 
 
N,N´-Dimethyl-N-
(iodoacetyl)-N´-(7-
Nitrobenz-2-oxa-1,3-diazol-
4-yl)ethylenediamine (NBD) 
Monobromobimane  
λmax excitation = 390nm 
 
λmax emission = 490nm 
λmax excitation = 500nm 
 
λmax emission = 550nm 
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In this dissertation, fluorescence spectroscopy was implemented to address several 
different questions. Interaction of different sites on arrestin with the membrane were 
observed using fluorescently-labelled arrestin in conjunction with spin-labelled fatty 
acids, which act as quenching agents and are able to spontaneously insert into the 
membrane. In addition, mutation of selected sites on arrestin to tryptophan, which 
quenches fluorophore emission when located in a close proximity (<10Ȧ), allowed 
conformational changes occurring in arrestin upon interaction with different forms of the 
receptor to be monitored, through intramolecular quenching. Finally, through attaching 
fluorophores on the arrestin-rhodopsin binding site, binding of arrestin to rhodopsin at 
varying concentrations allowed for determination of the binding stoichiometry of the 
interaction. The theoretical basis of these processes are described below, with information 
taken from the book Principles of Fluorescence Spectroscopy (Lakowicz 2010). 
 
2.1.1 Overview of the physics of fluorescence  
Fluorescence spectroscopy relies on the principle of electron excitation by a photon of 
light, and the subsequent release of energy as the electron returns to the ground state 
energy level. The wavelength of light is related to energy by the formula E = hν, where E 
= energy, h = Planck constant, and ν is the frequency of light. When a molecule absorbs 
a photon of light, the resulting energy can be enough to excite an electron into a higher 
energy orbital. When the electron returns to its ground state energy level, the energy 
difference is emitted. This process is shown in figure 2.2.  The ground state (S0) can be 
defined as the highest occupied molecular orbital (HOMO), and the excited state (S1) the 
lowest unoccupied molecular orbital (LUMO). In the case of fluorophores, the energy 
difference between the LUMO and the ground state is sufficiently high that the emitted 
energy is released as a photon of visible light, which can be detected.  
The S1 and S0 states are made up of different vibrational levels, and therefore the excited 
electron loses energy through very fast vibrational relaxation processes before emitting a 
photon of light to return to the ground state. As a lower energy corresponds to a longer 
wavelength of light, this explains why the emission wavelength of the fluorophore is 
longer than the exciting wavelength.   
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Figure 2.2 Jablonski diagram 
The basic Jablonski diagram depicts the principles of absorbance and fluorescence. Upon 
absorption of a photon of light, the electron is excited to a higher energy orbital, termed the S1 
excited state. The electron loses energy very quickly, on the picosecond timescale, through 
vibrational relaxation and interconversion, until it occupies the lowest vibrational orbital in the 
S1 state. The electron then returns to the ground state, on a nanosecond timescale, and emits 
energy released as a photon of light, which is detected as fluorescence. Figure adapted from 
Principles of Fluorescence Spectroscopy (Lakowicz 2010) 
 
2.1.2 Quantum yield and fluorescence lifetime 
The quantum yield of a fluorophore determines the proportion of photons emitted 
compared to photons absorbed by the molecule 
The quantum yield is given by the equation:  
       ϕ      =      
𝛤
𝛤+Knr
 
Where ϕ = quantum yield, Γ = emissive rate of the fluorophore, and Knr = rate of non-
radiative decay to the ground state (Lakowicz 2010).  
All quantum yields are less than 1, as a fluorophore will never emit all of the energy 
absorbed as fluorescence, as explained above. However, the closer the quantum yield is 
to 1, the brighter it will be.  
 
S1 Excited state 
S0 Ground state 
Absorbance Fluorescence 
Vibrational relaxation 
Vibrational relaxation 
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The lifetime of a fluorophore, is the amount of time that the molecule spends in the excited 
state, before returning to the ground state. This is given by the equation: 
τ = 
1
𝛤+𝐾𝑛𝑟
 
where τ = lifetime, Γ = emissive rate of the fluorophore, and Knr = rate of non-radiative 
decay to the ground state (Lakowicz 2010). 
In reality, individual molecules of the same fluorophore type will emit fluoresced photons 
at different times, and τ describes the average value for the population. For many 
fluorophores covalently attached to proteins, as with monobromobimane-labelled arrestin 
used in this dissertation, there is more than one lifetime. This is due to the heterogeneous 
environment of the fluorophore, caused by protein mobility. Therefore, it is useful to 
measure both the lifetime and the proportion of fluorophores in the sample with each 
lifetime.  
 
2.1.3 Solvent relaxation effect 
Not all fluorophores in the excited state will emit energy as fluorescence. Instead other 
processes can occur which cause transition to the ground state in a non-radiative way. 
These include collision with small solvent molecules, energy transfer to nearby 
molecules, or complex formation. Therefore, the observed fluorescence of a fluorophore 
is highly dependent on its environment, which is a useful tool for determining 
conformational changes in the protein at the site to which the fluorophore is attached.  
One very simple tool is the change in intensity observed when the fluorophore is in a 
hydrophobic environment as compared to a hydrophilic environment. When the molecule 
is in a hydrophilic environment, more energy will be lost from the excited state of the 
fluorophore due to collisions. In general the dipole moment of the molecule in the excited 
state is larger than in the ground state. As the rotational movement of small molecules 
such as water, are rapid, there is time for the solvent molecules to rearrange around the 
dipole moment of the excited state, before the molecule fluoresces, and the resulting 
collisions result in a loss of energy from the excited state. Therefore a loss of fluorescence 
intensity, as well as a red-shift of the emission spectrum, is observed when the 
fluorophore is present in an aqueous environment. When the fluorophore is embedded in 
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a hydrophobic environment (e.g. protein interior or lipid phase of membrane), it is 
protected from these solvent effects.  
 
2.1.4 Quenching 
Molecular quenching is a process by which fluorescence intensity is reduced through 
physical interaction of the fluorophore and another molecule, i.e. the quencher. 
Quenching can either be dynamic; whereby the quencher collides with the fluorophore 
during the lifetime of the excited state, resulting in return to ground state without emission 
of a photon, or static; which results from the quencher forming a complex with the 
fluorophore in the ground state, to create a non-fluorescent complex, as shown in figure 
2.3  
 
 
  
  
  
 
 
 
  
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Mechanisms of quenching 
Top: when the fluorophore (yellow circle) and quencher (blue circle) are far apart, there is no 
effect on fluorescence.  
Middle: When the fluorophore and quencher are in close proxinity the quencher can collide 
with the excited fluorophore resulting in a decreased fluorescence intensity and lifetime. 
Dynamic 
quenching 
Fluorophore quencher 
unquenched 
Static 
quenching 
quenching 
quencher 
Fluorophore 
Fluorophore 
Fluorophore 
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Bottom: Static quenching forms a non-fluorescent complex in the ground state, and no 
fluorescence is observed for the complexed molecule (grey circle).  
Figure adapted from (Mansoor, Dewitt et al. 2010) 
 
Quenching is a useful tool in protein interactions in order to identify regions either on the 
same protein, or on interacting proteins, that are in contact. If there is no change in 
fluorescence intensity in the absence and presence of the quencher, the two regions of the 
protein must be distant from each other. If there is a decrease in fluorescence, however, 
then either dynamic or static quenching must be occurring. Steady-state fluorescence 
spectroscopy only provides information about the intensity of the fluorescence, and 
therefore can only distinguish whether a sample is quenched or unquenched. In order to 
determine whether the quenching is dynamic or static, time-resolved spectroscopy is 
required, which also calculates the fluorescent lifetime of the sample. With static 
quenching a non-fluorescent complex forms, resulting in a decrease in overall 
fluorescence but no change in the fluorescence lifetime. This is because static quenching 
has no effect on any excited molecule. With dynamic quenching, however, the quencher 
interacts with the excited molecule. This decreases both the intensity and the lifetime of 
the fluorophore, and therefore the two fluorescence quenching mechanisms can be 
distinguished from each other (Mansoor, Dewitt et al. 2010).  
 
2.1.4.1 Mechanisms of dynamic quenching 
Dynamic quenching occurs by three main processes. These processes are not mutually 
exclusive, and it is likely that a combination of more than one are responsible for the 
quenching effect. The mechanisms are shown in more detail below:  
1. Intersystem crossing where the contact with the quencher causes the fluorophore 
to become a triplet state. Triplet states are lower in energy than the excited single 
state, and are much longer-lived. Therefore, loss of energy to the ground state 
occurs by non-radiative decay (Knr), with energy lost through collisions (see 
figure 2.4). 
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2. Electron exchange involves the excited state fluorophore transferring the excited 
electron to the LUMO of the quencher. The quencher then transfers back an 
electron to the fluorophore, in the ground state. This mechanism results in no 
fluorescence, but the quencher remains in an excited state (figure adapted from 
(Lakowicz 2010)) 
 
  
  
  
  
  
  
  
 
 
 
 
3. Photo-induced electron transfer this is similar to electron exchange, but only 
involves 1 electron transfer, and therefore results in both molecules having a 
charge, through which they form an ionic complex. In photo-induced electron 
transfer the electron donor can be either the fluorophore or the quencher 
(Lakowicz 2010). 
 
 
Figure 2.4 Intersystem crossing 
Dynamic quenching occurs by the fluorophore becoming a triplet state. 
figure adapted from (Lakowicz 2010)  
Figure 2.5 Electron exchange 
Dynamic quenching involving transfer of electrons between the fluorophore and the 
quencher. 
Figure adapted from (Lakowicz 2010) 
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2.1.4.2 Examples of quenching agents 
Tryptophan induced quenching (TrIQ) 
Tryptophan, and to a lesser extent tyrosine, are able to quench fluorescence due to their 
large electronegative rings, and therefore are useful for studying protein interactions 
(Mansoor, Dewitt et al. 2010). In this study, double mutations of arrestin were carried out 
such that a fluorophore was attached at one site, and a tryptophan introduced into a 
secondary site. This then allowed for conformational changes in arrestin to be monitored 
when bound to different forms of the receptor, as the distance between the two mutated 
sites was followed.   
Iodide quenching 
Another method of quenching useful with fluorophore-labelled proteins is iodide 
quenching. Small halide ions are able to act as collisional quenchers, by spin-orbit 
coupling to the triplet state of the excited fluorophore. When these ions collide with the 
activated fluorophore, they result in a decreased lifetime of the excited state, and the 
intensity of fluorescence in lowered. By measuring the fluorescence spectra of a 
fluorescently labelled protein in a halide solution, the environment of the fluorophore can 
be determined. When it is solvent exposed there will be more opportunity for collisions 
between the ions in the solution and the fluorophore, and therefore more quenching will 
be observed, than when the fluorophore is buried in the interior of the protein or the 
binding pocket.   
Spin-labelled fatty acids 
Attachment of a fluorescence quencher group to fatty acids allows for proximity of 
fluorescent probes with the membrane to be determined. Experiments described in this 
dissertation monitored membrane association of fluorescently-labelled arrestin by 
measuring the degree of quenching occurring between the fluorophore and a nitroxide 
spin-label quenching group, placed at varying positions on the acyl chain of the fatty acid. 
The fluorophore quenching mechanism by the spin label is not completely understood, 
and it is possible that multiple mechanisms are involved. As the spin labels are 
paramagnetic, it can be expected that they are able to quench fluorescence in a similar 
way to Oxygen, through intersystem crossing (described in section 2.1.4.1). In this 
mechanism of quenching the excited fluorophore becomes a triplet state, which has a 
lower energy and is longer lived than the singlet state, making it more likely that return 
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to the ground state occurs through non-radiative decay. Nitroxide spin labels have also 
been observed to quench fluorescence through electron transfer (as described in section 
2.1.4.1). In this mechanism electron transfer between the fluorophore and the quencher 
results in the quencher remaining in the excited state, and as no direct transition occurs 
from the excited state to the ground state of the fluorophore, quenching occurs.  
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2.2 Methods 
 
2.2.1 Preparation of Rod Outer Segment Membranes 
Bovine eyes were obtained from either W.L. Lawson Company (USA) or Teterow 
slaughter house, Germany, and retina were mechanically extracted and stored in 40% 
sucrose solution at -80°C. Rod outer segment membranes (ROS) were then separated 
from the rest of the cells using a sucrose gradient, using a protocol previously described 
in Sommer et al 2012 and was carried out under dim red light conditions. 100 retina were 
thawed and shaken for 4 minutes in 45% (weight to volume) sucrose solution in ROS 
buffer (70mM potassium phosphate, 1mM MgCl2, 0.1mM EDTA, 1mM DTT, 0.5mM 
PMSF, pH 7), and centrifuged in a fixed angle rotor for 5 minutes at 2500g. The 
supernatant was filtered through gauze and diluted 1:1 with ROS buffer, slowly so as to 
avoid osmotic shock, and then centrifuged for 7 minutes at 6000g. Three sucrose solutions 
in ROS buffer were prepared and the density tested using a hydrometer: 25.5% 
(1.105g/ml), 27.125% (1.115g/ml), 32.25% (1.135g/ml). The pellets were suspended in 
25.5% sucrose solution, and then layered on top of four gradients consisting of 27.125% 
sucrose solution underlaid with 32.25% sucrose solution. The gradients were centrifuged 
using a swinging bucket rotor, with slow start and stop settings, at 83,000g for 30 minutes. 
ROS membranes were then collected from the sucrose gradient interface using a syringe 
fitted with an 18ga needle. The ROS membranes were then diluted 1:1 in ROS buffer, 
mixed and centrifuged for 30 minutes at 48000g. The pellets were then resuspended in 
ROS buffer and stored at -80°C.  
 
2.2.2 Phosphorylation of Rhodopsin 
ROS membranes were phosphorylated under illuminated conditions, using the native 
rhodopsin kinase present in the membranes. First, the ROS membranes were 
homogenized using a 50mL glass douncer, in 100mM potassium phosphate buffer, pH 
7.4. 8mM ATP and 2mM MgCl2 were added, and the tubes were placed on a rocking 
platform and illuminated using a standard desk lamp. After 2 hours 50mM hydroxylamine 
was added, and incubated at room temperature for 10 minutes to convert all light-
activated rhodopsin to opsin. Membranes were washed four times in 100mM potassium 
phosphate buffer pH7.4, followed by one wash in 50mM Hepes buffer pH7. Washing 
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involved centrifugation for 30 minutes at 48000g, followed by resuspension of the pellets 
in buffer and homogenization in the douncer. After the final wash pellets were 
resuspended in 50mM Hepes buffer, pH7, and aliquoted into small fractions and snap 
frozen in liquid nitrogen, for storage at -80°C.  
 
2.2.3 Regeneration of Opsin to Rhodopsin 
Regeneration of the washed phosphorylated opsin (OpsP) to rhodopsin (RhP) was 
achieved by incubating with a 3-fold molar excess of 11-cis-retinal for one hour. The 
reaction was terminated by the addition of 20mM o-tert-butyl-Hydroxylamine. The 
concentration of rhodopsin was determined by measuring the difference in absorbance at 
500nm (extinction coefficient 0.0408 µM-1cm-1) after photo-bleaching, in the presence of 
100mM hydroxylamine. Photo-bleaching was carried out in the presence of  >495nm 
filter for 15s. The loss in absorbance at 500nm corresponds to the change in absorbance 
of the ligand as it isomerises from 11-cis-retinal (λmax 500nm) to all-trans-retinal (λmax 
380nm).  
 
2.2.4 Extra-Meta-II assay 
This assay quantifies the fraction of receptors significantly phosphorylated (2-3 
phosphates) (Gurevich and Benovic 1993, Gurevich and Benovic 1995, Mendez, Burns 
et al. 2000) to allow for arrestin binding, and is described in (Parkes and Liebman 1984). 
Arrestin binding is monitored through its ability to stabilize the active Meta-II receptor 
species. The assay is carried out in conditions which favour Meta-I (2°C, 50mM Hepes 
buffer pH 8). Formation of Meta-II (λmax 380nm) from Meta-I (λmax 480nm) after 
photo-bleaching with a short flash (>495nm) can be determined through following the 
increase in absorbance at 380nm. The amount of Meta-II stabilized in the presence of 
arrestin is compared to the amount stabilized in the presence of a high-affinity transducin 
peptide which binds the receptor in a phosphorylation independent manner. ROS 
membranes containing rhodopsin to which >95% was bound by arrestin were used for 
further experiments.  
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2.2.5 Preparation of arrestin mutants 
Arrestin mutants were created using a recombinant bovine arrestin-1 construct lacking 
the native cysteine and tryptophan residues (C63A, C128S, C143A, W194F), which is 
cloned in the pET15b vector. Mutations were made by PCR, with primers ordered from 
Sigma Aldrich and sequenced by LGC genomics. The plasmid DNA was expressed in 
Escherichia coli XL1-Blue supercompetant cells (Stratagene 200518) and isolated with 
miniprep kits from ThermoFischer Scientific. E.coli BL21 (DE3) competent cells (New 
England BioLabs) were transformed with plasmid DNA and incubated overnight at 30° 
on ampicillin-containing medium. A single colony was selected and used to inoculate 5ml 
LB medium with ampicillin (100µg/ml), which was incubated for 8h at 28°C, with 
shaking. 1ml from this culture was used to inoculate 150ml LB medium with ampicillin. 
This culture was incubated overnight at 28°C in a shaking incubator, and then split 
between four flasks with 2L LB medium with ampicillin, and 30µM IPTG was added 
once the cell density reached an optical density of 0.6 at 600nm. This culture was 
incubated for 16h at 28°C, and then cells were harvested by centrifugation at 5000g for 
15 minutes. The cells were lysed by resuspension in lysis buffer (10 mM Tris-HCl, 2 mM 
EDTA, 100 mM NaCl pH 7.5 + 5 mM DTT), and DNAse II was added, before 
microfluidising. The suspension was centrifuged for 30 minutes at 27000g, and the 
supernatant was mixed with ammonium sulphate (0.32g/ml) for protein precipitation. 
Centrifugation at 27000g for 30 minutes precipitated the protein and the pellet was 
resuspended in 10 mM Tris-HCl, 2 mM EDTA pH 7.0 + 5 mM DTT. A subsequent 
centrifugation step at 27000g for 30 minutes removed the insoluble protein, and the 
supernatant was filtered through a 0.8µm cellulose filter and loaded to 3 x 5ml HiTrap 
Heparin columns (GE healthcare), diluted 1:3 with 10 mM Tris-HCl, 2 mM EDTA, 100 
mM NaCl pH 7 + 5 mM DTT. Arrestin was eluted by a NaCl gradient (0.1 – 0-5 M). 
Fractions containing arrestin were identified by SDS-PAGE, pooled, and loaded onto a 5 
ml HiTrap SP column linked to a 5 ml HiTrap Q column, diluted 1:10 with 10 mM Tris-
HCl, 2 mM EDTA pH 8.5 + 5 mM DTT buffer. Arrestin was eluted with a two-step NaCl 
gradient: 0 – 0.1 M and 0.1 M – 0.5 M NaCl. The arrestin-containing fractions were 
identified by SDS-PAGE and pooled. The pooled arrestin was concentrated and 
exchanged into 50mM Hepes, 130mM NaCl, pH7 using spin columns (Amicon-Ultra 
0.5). The concentration was determined by absorbance at 280nm (Extinction coefficient 
of 0.02076µM-1cm-.1). Arrestin was then aliquoted, snap frozen, and stored at -80°C.  
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2.2.6 Labelling of arrestin mutants 
Arrestin mutants were labelled with thiol-reactive fluorophores for site-directed 
fluorescence. The fluorophores used were monobromobimane or N,N’-Diemthyl-N-
(Iodoacetyl)-N’-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Ethylenediamine) (NBD). The 
fluorophores were dissolved in DMSO, and the concentration was determined by diluting 
an aliquot by 1:1000 in ethanol. Monobromobimane has a λmax at 380nm (extinction 
coefficient of 0.005µM-1cm-1) and NBD has a λmax of 500nm (extinction coefficient of 
0.025µM-1cm.1).  
Arrestin mutants were thawed and diluted to 50µM in 50mM Hepes, 130mM NaCl pH 7. 
Monobromobimane or NBD were added at a 50-fold molar excess, and the sample was 
gently shaken on a platform, in the dark, for 3h. The excess fluorophore was removed 
through washing three times using an Amicon-Ultra 0.5 spin column, with 50mM Hepes, 
130mM NaCl, pH7, followed by size exclusion using G-15 sephadex in microcolumns 
(Sigma Aldrich).  
Note on nomenclature: for each single cysteine arrestin mutant, labelling with bimane is 
denoted by B, and when labelled with NBD is denoted with NBD, for example the arrestin 
mutant I72C, when labelled with bimane becomes I72B and when labelled with NBD 
becomes I72NBD.  
 
2.2.7 Preparation of ROS membranes enriched with spin labelled fatty acids 
ROS membranes were enriched with the following fatty acids: 
1. 2-(3-Carboxypropyl)-4,4-dimethyl-2-tridecyl-3-oxazolidinyloxy (5-doxyl-stearic 
acid) (Sigma-Aldrich) 
2. Methyl palmitate (Sigma-Aldrich) 
3. Stearic acid (Sigma-Aldrich) 
4. 4-Palmitamido-2,2,6,6-tetramethylpiperidine-1-oxyl (N-tempoyl palmitamide) 
(Avanti polar lipids) 
The fatty acids were dissolved in ethanol to a stock concentration of 10mM. Membranes 
containing phosphorylated rhodopsin (RhP) were diluted to a concentration of 5µM in 
2ml 50mM Hepes, pH 7. Fatty acids were added gradually to the membranes at 30°C, 
with a volume of 2µl every 2 minutes, to a final fatty acid concentration of 250µM, 
followed by incubation for 1h at 30°C whilst gently shaking, adapted from the protocol 
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by (Watts, Volotovski et al. 1979). This method allows for incorporation of fatty acids 
into the membrane, without forming micelles. As a control the same volume of ethanol 
was also added to ROS membranes.  
 
2.2.8 Centrifugal Pull-down Analysis 
This assay measures arrestin binding to ROS membranes, using centrifugal force to pellet 
the membranes, along with any associated arrestin.  
Determination of arrestin binding to ROS membranes enriched with spin-labelled 
fatty acids 
 In order to determine that all monobromobimane-labelled arrestin was bound to the 
receptor in the fluorescence quenching assays with ROS membranes enriched with spin-
labelled fatty acids, samples were prepared with the concentrations used in the 
fluorescence measurements (1µM arrestin + 4µM ROS membranes) enriched with each 
of the fatty acids, under dim red light. Samples measuring binding to the active receptor 
were photo-bleached (>495nm) for 15s. Samples were centrifuged for 10 minutes at 
16000g. The supernatant was removed, and the pellets resuspended in loading buffer 
containing 2% SDS, and SDS-PAGE was carried out. Gels were stained with Coomassie 
Brilliant Blue. 
Centrifugal pull-down assay titrations 
Titrations determining the amount of arrestin bound at varying concentrations of the 
receptor or arrestin were also carried out. These titrations used arrestin labelled with 
NBD for analysis by UV-VIS spectrometry.  
Both receptor and arrestin titrations were carried out, with final concentrations of 0, 0.5, 
1, 2, 4, 6, 10 and 12µM, against a final concentration of 4µM arrestin or receptor, 
respectively. All samples were prepared under dim red light, and those samples 
monitoring binding to the light-activated receptor, were photo-bleached (>495) for 15s. 
Samples were centrifuged for 10 minutes at 16000g. The supernatant was carefully 
removed and a UV-VIS absorbance spectrum was taken. The NBD signal (λmax 500nm, 
extinction coefficient of 0.025µM-1cm-1) was recorded. The concentration of NBD-
labelled arrestin in the supernatant was subtracted from the total concentration of NBD-
labelled arrestin in the sample to provide the concentration of arrestin pulled down by the 
ROS membranes.  
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Analysis of centrifugal pull-down titrations  
Titration results were analysed using Sigmaplot graph fitting software.  
Graphs were produced with the concentration of the variable (titrator) on the x axis, 
against the concentration of arrestin pulled down on the y axis.  
Mathematical analysis of centrifugal pull down titration curves  
The data were fit to a curve derived from the definition of the dissociation constant (Kd):  
Kd =  
[𝐴][𝑅]
[𝐴𝑅]
 
The total amount of arrestin (Atot) and receptor (Rtot) are given by: 
Atot = [A] + [AR] and Rtot = [R] + [AR] 
Fitting these equations into the Kd equation, and rearranging gives the equation:  
[AR] = k.
(𝑝−√(𝑝2−4𝑞))
2
 
Where p = Kd + [Atot] + [Rtot], q = [Atot].[Rtot] and k = scalar factor to scale the 
experimental data to concentration units.  
For each graph the Kd and stoichiometry were obtained from the fit.  
For arrestin titrations the independent variable was [Atot], with the Kd and [Rtot] being 
dependent variables. The dependent [Rtot] was indicative of the concentration of arrestin 
bound, and therefore of the final binding stoichiometry.  
For receptor titrations the independent variable was [Rtot] , with the Kd and [Atot] being 
the dependent variable. In this case, the concentration [Atot] was indicative of the 
concentration of arrestin bound, and therefore of the final binding stoichiometry.      
 
2.2.9 Steady-state fluorescence 
Steady-state fluorescence was measured on a SPEX Fluorolog 1680 instrument in front 
face mode. Excitation slits were set at 0.3mm to minimize bleaching of rhodopsin, and 
emission slits were set at 4mm. For monobromobimane-labelled arrestin mutants 
excitation was at 400nm and emission was measured from 420nm – 600nm, (2nm step 
size, 0.5s integration per point). For NBD-labelled arrestin mutants excitation was at 
500nm and emission was measured from 520nm – 700nm (2nm step size, 0.5s integration 
per point). For measurements with light-activated rhodopsin, samples were illuminated 
for 10s with 150W fibre optic light source (>495nm) 
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Analysis of steady-state fluorescence data 
Sigmaplot graph fitting software was used to analyse the data. Background fluorescence 
was subtracted, and graphs were plotted of fluorescence count (cps) against wavelength. 
For analysis of titration experiments the integrated fluorescence of each of the curves was 
calculated, and plotted against the concentration of the titrator.  
Analysis of quenching efficiency of spin-labelled fatty acids 
The integrated fluorescence of each mutant in the presence of the spin labelled fatty acid 
was compared to the integrated fluorescence of each mutant in the presence of the 
corresponding fatty acid lacking the spin-label: for N-tempoyl palmitamide this control 
was methyl palmitate and for 5-doxyl stearate this control was stearic acid.  
2.2.10 Time-resolved fluorescence spectroscopy 
Time-resolved fluorescence experiments were carried out using a Fluotime 300 
spectrometer from Picoquant. The laser used was 375nm, pulsed diode laser, and 
emission was measured at 480nm. The intensity of fluorescence was measured, and a 
graph of the intensity decay (log I(t) against time (t) was produced, using the software 
FluoFit from Picoquant. The data collected was deconvoluted to a decay curve, using the 
instrument response function (IRF), which was determined with a solution of Ludox. The 
IRF is a deviation from a “perfect” system which would have an infinitely small excitation 
pulse-width, and infinitely accurate detectors and electronics. The lifetimes were fit using 
χ2 analysis to determine the best fit. As each of the samples reported more than one 
lifetime, the calculated average amplitude weighted lifetime was used. The amplitude 
weighted lifetime value reports the lifetime a single fluorophore with the same steady-
state intensity as the sample would have, and therefore is proportional to the steady-state 
fluorescence (Sillen and Engelborghs 1998). It is calculated with the formula: 
amplitude weighted lifetime = ∑αiτi   
where α = fraction of fluorophores with each lifetime, τ.   
 Quantum yield calculation 
Quantum yield, which is a measure of the number of photons emitted from a fluorophore 
as compared to the number absorbed, can be determined by comparing the fluorescence 
to a standard which fluoresces in a similar region to the molecule in question. The ratio 
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of the absorbance and fluorescence of the standard can then be compared to the molecule 
in question, as related by the equation:  
ϕu ∝ ϕs (
𝐴𝑠𝐹𝑢
𝐴𝑢𝐹𝑠
)  
Where ϕu is the quantum yield of the unknown sample, ϕs is the quantum yield of the 
reference, As and Au are the absorbance of the reference and unknown sample 
respectively, and Fu and Fs are the fluorescence intensities of the unknown sample and 
reference respectively.  
In this work the quantum yields were determined by using quinine sulphate, which 
absorbs at 340nm, and has a quantum yield of 0.55 (Eaton 1988). 
The time-resolved fluorescence measurements were carried out in low salt (50mM Hepes, 
pH 7) buffer. However, under these conditions there is some aggregation of arrestin, 
which leads to error due to scattering when measuring the absorbance of the sample. 
Therefore, the quantum yield of each of the mutants was initially measured in isotonic 
buffer (50mM Hepes, 130mM NaCl, pH 7). Salt titrations monitoring fluorescence 
intensity, then allowed for determination of the quantum yield of each of the mutants in 
low salt buffer by multiplying the quantum yield of the mutant in isotonic buffer by the 
observed fluorescence change. The quantum yield in the presence of 2.5mM IP6 was 
similarly determined by titration curves at different concentrations of IP6. 
 
Calculation of quenching efficiency 
Quenching was calculated by comparing the amplitude weighted lifetimes and the 
quantum yield of the fluorophore in the presence and absence of the quencher, tryptophan.   
The following equations were used to calculate quenching (Mansoor, Dewitt et al. 2010):  
Equation 1 calculates the fraction of fluorophores present which are uncomplexed in the 
ground state, and are free to fluoresce. Fw corresponds to the quantum yield of the 
fluorophore in the presence of the quencher, and F0 is the quantum yield in the absence 
of the quencher. τ is the lifetime of the fluorophore, with τw with quencher and τ0 without 
the quencher.  
1. γ = 
𝐹𝑤
𝐹0
 . 
𝜏0
𝜏𝑤
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Fluorophores which are statically quenched form a non-fluorescent complex in the 
ground state, and therefore the fraction of statically quenched fluorophores is given by 
equation 2: 
2. 1 – γ 
The fraction of uncomplexed fluorophores calculated in equation 1 represent two 
populations: the fluorophores that are unquenched (γF), and the fluorophores that are 
dynamically quenched (γDQ). By using equation 1 therefore, the fraction of both of these 
populations can be calculated.  
The fraction of fluorophores which emit light without being quenched is given by 
equation 3:  
3. γF = 
𝜏𝑤
𝜏0
 . γ 
The fraction of fluorophores which are dynamically quenched, is then calculated by 
equation 4: 
4. γDQ = (1 −
𝜏𝑤
𝜏0
) . γ 
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3. Results 
3.1 The C-edge of arrestin functions as a membrane anchor 
 
3.1.1 Introduction 
The initial proposal that the C-domain could interact with the membrane came from 
experiments which monitored fluorescence changes on the finger loop and the 344-loop 
of arrestin, when bound to different functional forms of rhodopsin (Sommer, Hofmann et 
al. 2012). The fluorescence of a monobromobimane fluorophore attached at site 72 (I72B) 
on the finger loop was directly proportional to the amount of arrestin bound to the light-
activated phosphorylated receptor (Rh*P), but showed a minimal fluorescence change 
when bound to OpsP, even though pull-down experiments showed comparable binding 
to both forms of the receptor. Conversely the fluorescence of the monobromobimane 
fluorophore attached to site 344 (S344B) on the C-edge, was directly proportional to the 
amount of arrestin bound, in both the presence and absence of the ligand. The pull down 
analysis for both mutants indicated a binding stoichiometry of one arrestin to 1.4 Rh*P, 
suggesting a mixture of one-to-one and one-to-two stoichiometries. The authors therefore 
proposed a model to explain arrestin binding to either one or two receptors. In the case of 
a one-to-two stoichiometry the finger loop was proposed to insert into the active binding 
crevice of Rh*P, with the 344-loop contacting a neighbouring receptor. In the case of a 
one-to-one stoichiometry, the finger loop engages Rh*P with the 344-loop inserting into 
the membrane (see figure 3.1.1).  
 
 
 
 
 
 
 
 
Further support for the idea that the C-domain of arrestin could interact with the 
membrane arose from the crystal structure of the Ops*/arrestin-1 complex (Kang, Zhou 
Figure 3.1.1 Model showing the 
interaction of arrestin with light-
activated rhodopsin (Meta-II) in a 
one-to-one and a one-to-two 
stoichiometry.  
The finger loop is highlighted in 
magenta and the 344-loop in orange.  
Figure taken from Sommer, Hofmann 
and Heck (2014) Handbook Exp 
Pharma 
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et al. 2015). The crystal structure obtained was of constitutively active mutant human 
rhodopsin in complex with constitutively active mouse arrestin-1, fused via a 15 residue 
linker. The structure shows an asymmetric orientation of arrestin in complex with 
rhodopsin. The N-domain interacts extensively with the active receptor, and the finger 
loop is buried within the active receptor crevice. Due to the interdomain rotation present 
in the active arrestin, the C-domain is tilted, and the authors speculated that in this 
orientation interaction with the membrane is possible. As there was no membrane present 
in the crystal structure, this could not be confirmed. However, the C-edge of arrestin 
contains a patch of highly conserved hydrophobic residues (L342, L339, F197, F198), 
and mutation of these sites to alanine has been found to decrease binding of arrestin to 
Rh*P (Ostermaier, Peterhans et al. 2014). Given the large distance of these residues to 
the receptor binding site, it is possible that the membrane serves as an additional binding 
site in the arrestin-receptor complex. 
In this section, experiments are presented to probe the role of the arrestin C-edge in 
membrane interaction. The approach was based on the quenching of fluorophores 
attached to specific sites on arrestin by spin-labels present in the membrane. Proximity of 
different sites on arrestin to the membrane were measured for both the dark-state pre-
complex with phosphorylated rhodopsin (RhP), and for the high-affinity complex with 
light-activated phosphorylated Meta II (Rh*P). Fluorescence data was compared to 
molecular dynamics simulations, which were performed by Dr Jana Selent (University 
Pompeu Fabra, Barcelona). These results have been published in: Lally CCM, Bauer B, 
Selent J, Sommer ME. (2017) C-edge Loops of Arrestin Function as a Membrane Anchor 
Nature Communications 8:14258. 
Fluorophore-labelling of arrestin mutants 
Arrestin was labelled with the fluorophore monobromobimane, at 16 different sites which 
had been individually mutated to cysteine in an arrestin construct lacking native cysteines 
(see methods 2.2.6) (figure 3.1.2).  
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Figure 3.1.2 Sites on arrestin-1 labelled with monobromobimane 
Arrestin 1CF1, chain A, The Cα of each of the sites on arrestin that were labelled with 
monobromobimane are shown as spheres. Green spheres show the Cα of residues in the N-
domain, and blue spheres in the C-domain.  
 
Enrichment of ROS membranes with spin-labelled fatty acids 
The proximity of each labelled site to the membrane was probed by enriching native ROS 
membranes containing phosphorylated rhodopsin with spin-labelled fatty acids. Fatty 
acids insert spontaneously into the membrane, and spin labels are known to quench 
monobromobimane fluorescence when in collisional distance ((Lakowicz 2010), 
although this is a new approach for investigating arrestin binding. Different spin-labelled 
fatty acids were employed, which contain the spin label at varying positions on the acyl 
chain, in order to assess proximity of each site on arrestin to different areas of the 
membrane. 4-palmitamido-TEMPO reports proximity to the membrane surface 
(phospholipid head-group region), 5-doxyl-stearic acid reports insertion into the 
hydrophobic region of the membrane (near carbon 5 on the acyl chain), and 10-doxyl-
nonodecane reports deep insertion into the membrane (near carbon 10 on the acyl chain).  
197- 
loop 
344-loop 
Finger loop 
160-loop 
Middle loop 
C loop 
Central crest loops 
C-edge loops 
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Initial experiments with ROS membranes enriched with 10-nonodecane showed no 
quenching, indicating that no sites on arrestin inserted this deep into the membrane. 
Further experiments focussed on 4-palmitamide TEMPO (N-tempoyl palmitamide) and 
5-doxyl stearic acid, which induced significant quenching for many bimane-labelled 
arrestin mutants. Quenching efficiency was calculated by comparing the fluorescence 
signal of arrestin in the presence of ROS membranes enriched with spin-labelled fatty 
acids with ROS membranes enriched with the corresponding fatty acids containing no 
spin label. For N-tempoyl palmitamide this control fatty acid was methyl palmitate, and 
for 5-doxyl stearic acid this control was stearic acid (see table 3.1.1). Control membranes 
which contained no fatty acid were also employed. In this case, ethanol was added at an 
equal volume to make them comparable to fatty acid-enriched membranes. 
Table 3.1.1 Structures of spin-labelled fatty acids and control fatty acids containing 
no spin label 
Spin Labelled Fatty Acids (SLFAs) 
Name Structure  Range of quenching 
4-palmitamido-
TEMPO  
(N-tempoyl 
palmitamide)  
 
Membrane surface 
5-Doxyl-Stearic acid  
 
Hydrophobic portion, 
around carbon-5 on 
the acyl chain) 
10-Doxyl 
Nonodecane 
 
Hydrophobic portion, 
around carbon-10 on 
the acyl chain 
Methyl palmitate  Control fatty acid, no 
spin label present 
Stearic acid  Control fatty acid, no 
spin label present 
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3.1.2 Quenching of fluorescently-labelled arrestin by spin-label fatty acids 
Measurements were carried out to monitor arrestin interaction with dark-state 
phosphorylated rhodopsin (RhP) in the pre-complex, as well as after photo-activation 
with active phosphorylated rhodopsin (Rh*P) in the high-affinity complex. Therefore, for 
each arrestin mutant, a total of 11 measurements were performed for each data set:  
1. Unbound arrestin  
Arrestin + RhP (before photo-activation) 
2. ROS membranes + ethanol (no fatty acid present) 
3. ROS membranes + methyl palmitate 
4. ROS membranes + N-tempoyl palmitamide 
5. ROS membranes + stearic acid 
6. ROS membranes + 5-doxyl stearic acid 
Arrestin + Rh*P (after photo-activation) 
7. ROS membranes + ethanol (no fatty acid present) 
8. ROS membranes + methyl palmitate 
9. ROS membranes + N tempoyl palmitamide 
10. ROS membranes + stearic acid 
11. ROS membranes + 5-doxyl stearic acid 
 
Experimental conditions were chosen such that the amount of arrestin bound to dark state 
rhodopsin (pre-complex binding) was comparable to light-activated rhodopsin (high-
affinity binding). Pre-complex binding is a primarily electrostatic interaction, where 
arrestin binds to the phosphorylated receptor C-terminus. ROS membranes were prepared 
to yield high levels of rhodopsin phosphorylation (see methods section 2.2.2 and 2.2.4), 
and all of the receptors were confirmed to be sufficiently phosphorylated for arrestin 
binding. By reducing the salt concentration at which the experiments were carried out, 
electrostatic binding of arrestin to dark-state rhodopsin was maximised. The affinity, as 
determined by the dissociation constant (Kd), of arrestin to Rh*P has been calculated to 
be in the nanomolar range (Pulvermüller, Maretzki et al. 1997, Bayburt, Vishnivetskiy et 
al. 2011), compared to just 80µM for arrestin binding to RhP in the presence of 100mM 
NaCl (Zhuang, Chen et al. 2013). However, the Kd of arrestin binding to highly 
phosphorylated RhP in buffer with minimal salt has been reported to be 1µM (Sommer, 
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Hofmann et al. 2012). Therefore, by using an excess of receptor and minimal salt in the 
fluorescence experiments, comparable levels of arrestin binding to dark-state RhP and 
light-activated Rh*P were obtained (See supplementary figure 3.1.1, at the end of the 
chapter). Importantly, this allowed for direct comparison between quenching efficiencies 
between the pre-complex and the high-affinity complex, as there was minimal 
background signal from unbound arrestin.  
Example spectra for some of the mutants are presented in figure 3.1.3, and the calculated 
quenching efficiencies for all replicates, along with any wavelength shifts observed are 
presented in supplementary table 3.1.1 (presented at the end of the chapter).  
Figure 3.1.3 Example fluorescence spectra for bimane-labelled arrestin mutants 
with enriched ROS membranes grey = arrestin only, black = arrestin + ROS membranes 
containing RhP (left) or Rh*P (right). Blue = arrestin + ROS membranes enriched with N-
tempoyl palmitamide, red = arrestin + ROS membranes enriched with methyl palmitate, green = 
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arrestin + ROS membranes enriched with 5-doxyl stearic acid, orange = arrestin + ROS 
membranes enriched with stearic acid. Spectra are normalised such that the fluorescence 
intensity of unbound arrestin is 1. Figure taken from Lally CCM, Bauer B, Selent J, Sommer ME. 
(2017) C-edge Loops of Arrestin Function as a Membrane Anchor Nature Communications 
8:14258. 
The observed quenching efficiencies are shown in figure 3.1.4. The Cα of each site to 
which the bimane fluorophore was attached is represented as a sphere, whose colour 
corresponds to the quenching efficiency. 
 
Figure 3.1.4 Colour  map depicting quenching efficiencies of different sites on 
arrestin 
All mutants tested are shown on the structure of arrestin (PDB 1CF1, α chain), as spheres at 
the Cα residue of the amino acid to which a monobromobimane label was attached. The amount 
of quenching observed by top: 5-doxyl stearic acid and bottom: N-tempoyl palmitamide is 
depicted using the colour map: blue signifies no quenching, and red signifies quenching up to 
30%. Black spheres signify negative quenching (see main text).  
Figure taken from Lally CCM, Bauer B, Selent J, Sommer ME. (2017) C-edge Loops of 
Arrestin Function as a Membrane Anchor Nature Communications 8:14258 
 
C-edge loops of arrestin function as membrane anchor 
Most of the quenching observed is localised to the C-edge loops of arrestin. Interestingly, 
the pattern of quenching differs between the pre-complex and the high-affinity complex, 
indicating that association of the C-edge with the membrane changes orientation 
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depending on the activation state of the receptor (see figure 3.1.4, and supplementary 
table 3.1.1).  
 In the pre-complex the fluorophores at sites L342 and L339 were accessible to 5-doxyl 
stearic acid, (quenching efficiency of 30% and 15% respectively), suggesting insertion 
into the hydrocarbon core of the membrane. The fluorophore at site L342 was also 
quenched to a lesser degree by N-tempoyl palmitamide (11%) suggesting that it is 
positioned somewhere between the two spin labels. The other sites on the 344-loop: 344 
and 334 were quenched by the N-tempoyl palmitamide only (17% and 13% respectively), 
suggesting that they are making contact with the phospholipid head-group region of the 
membrane. None of the other loops on the C-edge were observed to contact the membrane 
in the pre-complex. 
Upon light-activation a change in orientation of the C-edge with respect to the membrane 
was observed. Monobromobimane fluorophores at sites 342, 339 and 344 all became 
accessible to quenching by both the N-tempoyl palmitamide (quenching efficiency of 
31%, 27%, 30% respectively) and 5-doxyl stearic acid (22%, 18%, 19% respectively), 
implying that they are located just inside the membrane interior. The sites 342 and 339 
are located closer to the membrane surface in the high-affinity complex as compared to 
the pre-complex, whereas site 344 moves further into the interior. Additionally site 197 
was quenched in the high-affinity complex, by both N-tempoyl palmitamide (23%) and 
5-doxyl stearic acid (23%), placing it just inside the hydrophobic portion of the 
membrane.  
In addition to the observed decrease in fluorescence intensity due to quenching, some of 
the mutants displayed a wavelength shift when bound to the ROS membranes, in 
particular at sites 72, 197, 339, 342 and 344. Wavelength shifts are associated with 
movement of the fluorophore into a more hydrophobic environment (see section 2.1 for 
more details). For the sites on the C-edge of arrestin, these wavelength shifts correspond 
to quenching by 5-doxyl stearic acid, indicating insertion in the hydrophobic portion of 
the membrane. For site 72 on the finger loop, however, the wavelength shift most likely 
corresponds to insertion into the hydrophobic binding pocket of the receptor. Indeed, an 
EPR study that measured the mobility of spin labels attached to arrestin (Hanson, Francis 
et al. 2006) supports this finding. The spin label at site 72 had a lower mobility when 
bound to RhP in the pre-complex as compared to the unbound state, and was almost 
completely immobilised in the high-affinity complex. In contrast, the spin label at site 
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344 had a lower mobility when bound to RhP in the pre-complex, and no further change 
in mobility was observed upon light-induced transition to the high-affinity complex. 
These results are consistent with site 344 being embedded in the fluid ROS membrane, 
whereas the loss of mobility observed at site 72 is consistent with binding to the receptor 
crevice.  
Some negative values were determined for quenching with 5-doxyl stearic acid, 
particularly at sites 271 and 159, and in the pre-complex at sites 344 and 334, resulting 
from a higher fluorescence intensity in the presence of 5-doxyl stearic acid as compared 
to stearic acid. A possible explanation for this could be due to the carboxyl head group of 
stearic acid, located in the polar region of the membrane.  Carboxyl groups are known to 
quench fluorescence, and negative quenching could arise from unequal abilities of the 
carboxyl group of 5-doxyl stearic acid and stearic acid to quench bimane fluorescence. 
Notably, all sites which displayed negative quenching by 5-doxyl stearic acid were 
quenched by N-tempoyl palmitamide, for which the spin label is located at the membrane 
surface. This correlation suggests close proximity of these sites to the carboxyl group.   
Association of the central crest loops and 160-loop with the membrane 
Some residues on the N-domain of arrestin also display quenching, particularly in the 
finger loop, which binds in the crevice of the active receptor and the middle loop, which 
undergoes a movement upon activation of arrestin (see Introduction section 1.3.3). In the 
high-affinity complex, quenching by N-tempoyl-palmitamide is observed for site 72. 
From the crystal structure of the ops*/arrestin-1 complex (Kang, Zhou et al. 2015), this 
residue is located at the base of the finger loop, and therefore is likely to be close to the 
membrane when the finger loop is bound to the receptor. Site 75, which is located at the 
tip of the finger loop, and according to available crystal structures is buried deep within 
the receptor crevice (Szczepek, Beyriere et al. 2014, Kang, Zhou et al. 2015) displays no 
quenching from N-tempoyl-palmitamide. Sites 139 and 251 on the middle loop and C 
loop respectively, show interesting quenching patterns. Site 251 is quenched by N-
tempoyl palmitamide in both the pre-complex (20%) and the high-affinity complex 
(23%). In the crystal structure this loop is seen to be near to the membrane surface, close 
to the cytoplasmic end of transmembrane 3. However, the site also displays quenching by 
5-doxyl stearic acid in the pre-complex and high-affinity complex (12% and 18% 
respectively). Similarly the site 139 is also quenched by 5-doxyl stearic acid in the pre-
complex (14%). This result is surprising, as in the crystal structure these sites are located 
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far from the membrane interior, and neither site displays the wavelength shifts indicative 
of localization in a hydrophobic environment. The observed quenching by 5-doxyl stearic 
acid, therefore, is not easily explained. However, it is possible that these loops may lie in 
a different orientation to that observed in the crystal structure, or that the observed 
quenching is due to the presence of the negatively charged carboxyl head-group of 5-
doxyl stearic acid.   
In the ops*/arrestin-1 fusion complex crystal structure (Kang, Zhou et al. 2015), the 160-
loop on the arrestin N-domain interacts with the cytoplasmic end of TM6 of the receptor, 
and this orientation places the 160-loop far from the membrane surface (>15Ȧ). This 
observation is consistent with biochemical studies employing Tryptophan-induced 
fluorescence quenching (TrIQ) (Sinha, Jones Brunette et al. 2014) which found that the 
160-loop of arrestin-1 came into contact with TM6 of opsin. However, quenching was 
observed by N-tempoyl palmitamide at site 161 in both the pre-complex and high-affinity 
complex (21% and 19%, respectively) as well as to a lesser extent at site 159 in the pre-
complex and high-affinity complex (5% and 9%, respectively). The fluorophore at site 
159 also displayed negative quenching in the presence of 5-doxyl stearic acid, indicating 
association with the membrane. Electron microscopy (EM) studies of arrestin-2 bound to 
a GPCR indicated binding modes where the finger loop of arrestin does not engage the 
receptor helical core (Shukla, Westfield et al. 2014, Thomsen, Plouffe et al. 2016). 
Although the visualized complexes are at low resolution, they suggest an interaction of 
the N-domain of arrestin with the receptor, which would place the 160-loop close to the 
membrane surface. This, along with the quenching data, suggest that these loops can be 
highly flexible, and adopt orientations bringing them into contact with the membrane 
surface.   
No interaction is observed between arrestin and the membrane in the absence of 
phosphorylated receptor 
In order to determine if the interaction of the C-edge of arrestin with the membrane was 
dependent on activation of arrestin by receptor attached phosphates, fluorescence 
quenching experiments were also carried out with ROS membranes containing non-
phosphorylated rhodopsin (see figure 3.1.5). 
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Figure 3.1.5 Fluorescence spectra of arrestin S344B (1 μM) and fatty-acid enriched 
ROS membranes containing non-phosphorylated rhodopsin (20 μM) 
black = arrestin + ROS membranes, blue = arrestin + ROS membranes enriched with tempo 
palmitate, green = arrestin + ROS membranes enriched with doxyl stearate 
Figure taken from Lally CCM, Bauer B, Selent J, Sommer ME. (2017) C-edge Loops of Arrestin 
Function as a Membrane Anchor Nature Communications 8:14258 
 
Arrestin mutant S344B in the presence of a large excess of fatty acid enriched ROS 
membranes containing non-phosphorylated rhodopsin, showed no quenching by N-
tempoyl palmitamide nor 5-doxyl stearic acid, in either dark-state conditions, or after 
photo-activation. This result indicates that the C-edge of arrestin does not spontaneously 
insert into the membrane, and that the membrane anchor acts as a functional binding 
element that is activated only when arrestin is bound to phosphorylated receptor in either 
the pre-complex or the high-affinity complex.  
 
3.1.3 Molecular dynamics simulations 
Fluorescence quenching experiments were complemented by molecular dynamics 
simulations, which were performed by Dr Jana Selent (University Pompeu Fabra, 
Barcelona). In these simulations, the isolated C-domain of arrestin was simulated with a 
lipid bilayer fragment composed of 1-stearoyl-2-docosahexaenoyl-sn-glycero-3-
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phosphocholine (SDPC). This approach reduced the system size so that longer 
simulations could be carried out.  
Unbiased simulations with the C-domain of basal arrestin (pdb 1CF1, α-conformer) found 
no interaction of arrestin with the membrane, and upon application of an energetic bias a 
deformation of the membrane was observed. In this conformation, the polar residues on 
the C-edge of arrestin (S344 and E341) were exposed, whereas the hydrophobic residues 
(L342 and L339) were buried within the β-sheets of the C-domain. Therefore, the 
repulsion between the C-edge and the membrane restricted membrane insertion. This 
finding correlates well with the fluorescence data which showed no membrane 
association of arrestin in the presence of ROS membranes containing non-phosphorylated 
rhodopsin.  
However, during one simulation, there was a spontaneous rearrangement of the 344-loop, 
to a conformation similar to that observed in the crystal structure of p44 (Kim, Hofmann 
et al. 2013). p44 is a pre-active splice variant of arrestin-1, lacking the regulatory C-tail, 
and is able to bind non-phosphorylated (Rh*) with a micromolar affinity (as determined 
by the Kd) as well as phosphorylated receptor, regardless of activation state, with high 
affinity (Schröder, Pulvermüller et al. 2002) (See Introduction section 1.3.2). In p44, the 
hydrophobic residues on the 344-loop (L342 and L339) are exposed. Therefore, further 
simulations were carried out using the C-domain of p44 (PDB: 4J2Q, chain B), and in 
this conformation membrane insertion occurred in 1 simulation out of 10, which is a 
statistically significant result. 
 
3.1.4 Comparison of fluorescence quenching data with molecular dynamics data 
Comparison of fluorescence quenching data with the molecular dynamics simulations 
showed that the orientation and conformation of the C-edge loops in the simulation most 
resembled the quenching experiments for the light-activated, high-affinity complex (see 
figure 3.1.6). In the molecular dynamics simulations, the hydrophobic residues L338, 
L339, L342, as well as F197 and M198, were embedded in the membrane, and polar 
residues including S344, S336 and E341 made transient contacts with the phospholipid 
layer of the membrane. In order to better compare the molecular dynamics and 
fluorescence data, the distance of the Cα of selected residues to either the phosphate layer 
of the membrane, or the carbon at position 5 on the acyl chain (C5), were calculated from 
the simulation. These distances approximate the position of N-tempoyl palmitamide and 
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5-doxyl stearic acid respectively. Overall the quenching efficiencies and simulated 
distances are very similar to each other. However, some differences are observed. In 
particular site 344 is predicted to be further away from both the phosphate layer and from 
C5 in the simulation data as compared to fluorescence quenching experiments. These 
differences can be explained by the fact that molecular dynamics data are derived from 
the isolated C-domain simulated in the absence of receptor, which allows more freedom 
of movement as compared to full-length arrestin in complex with the receptor. 
Furthermore, simulation-derived distances were calculated from the Cα of each residue, 
whereas fluorescence data was derived from a monobromobimane fluorophore attached 
to a cysteine residue many angstroms away from Cα. However, even with these 
limitations there is a strong correlation between the simulations and the fluorescence 
quenching profile derived for the high-affinity complex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.6 Comparison of 
fluorescence data with molecular 
dynamics simulations  
Left: Cα atoms of residues on arrestin 
are shown as spheres, coloured 
according to distance (0-20 Ȧ) from 
Carbon-5 on the acyl chain 
(approximate position of the 5-doxyl 
stearic acid spin-label), and to the 
phosphate head-group layer of the 
membrane (approximate distance of 
the N-tempoyl palmitamide head-
group).  
Right: Cα atoms of residues on 
arrestin labelled with 
monobromobimane are shown as 
spheres, coloured according to 
quenching efficiency (0–30 %) by 5-
doxyl stearic acid and N-tempoyl 
palmitamide, when bound in the high-
affinity complex to Rh*P.  
 
 Figure prepared by Jana Selent, Pompeu Universiry, Barcelona, and taken from Lally CCM, 
Bauer B, Selent J, Sommer ME. (2017) C-edge Loops of Arrestin Function as a Membrane 
Anchor Nature Communications 8:14258 
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3.1.5 Comparison of the molecular dynamics and fluorescence quenching data with 
the ops*/arrestin-1 fusion complex 
One frame from the simulation was selected based on the best fit to the arrestin C-domain 
and hypothetical membrane plane (which was determined using computational methods) 
of the ops*/arrestin-1 fusion complex (Kang, Zhou et al. 2015). An overlay of the selected 
frame and the crystal structure is shown in Fig. 3.1.7. As the 344-loop was unresolved in 
the crystal structure, this overlay effectively fills in structural details missing in the 
structure. This overlaid model shows that in this orientation residues L342, L339, S344 
and F197 could all make contact with the phosphate layer of the membrane, which fits 
well with the fluorescence quenching efficiencies by N-tempoyl palmitamide obtained 
after light-activation, of 31%, 27%, 30% and 23% respectively.  These residues were also 
located in close proximity to the C5 atom, which correlates well with quenching by 5-
doxyl stearic acid after light-activation by 22%, 18%, 19% and 23% respectively. This 
comparison indicates that the Ops*/arrestin-1 fusion complex crystal structure most likely 
resembles the high-affinity complex, and that the C-edge loops of arrestin adopt a 
conformation similar to that seen in the p44 structure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.7 Comparison of molecular dynamics simulations and fluorescence 
quenching data with the Ops*/arrestin-1 complex 
Left: superposition of the Ops*/arrestin-1 fusion complex crystal structure (green, PDB 
code = 4ZWJ), with a C-domain conformation selected from MD simulation (grey). The 
membrane layers were modelled by Jana Selent using computational tools…. 
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3.1.6 Conformation of the C-edge loops of arrestin in the pre-complex and high-
affinity complex.  
Comparison of molecular dynamics simulations employing the isolated C-domain of p44 
with fluorescence quenching data shows that the orientation of the C-edge loops in the 
simulations resembles that of the high-affinity complex. However, fluorescence data 
suggest that the C-edge has a different orientation and conformation in the pre-complex. 
In the pre-complex, sites 342 and 339 are more deeply inserted into the membrane than 
in the high-affinity complex, and the 197-loop does not engage the membrane at all. 
Based on these findings, it is possible the C-edge adopts a conformation similar to that 
seen in one of the crystallographic tetramers of basal arrestin. In the “open” conformation 
(molecules A and C in PDB structure 1CF1), the hydrophobic residues on the 344-loop 
are exposed, the polar residues buried, and the 197-loop is not orientated for interaction 
with the membrane (see figure 3.1.7). Therefore, based on the fluorescence and molecular 
dynamics data, it can be proposed that the conformation of the C-edge in the high-affinity 
complex is similar to the conformation of p44, and in the pre-complex is similar to the 
“open” basal conformation of arrestin.    
 
 
 
 
 
 
 
 
Figure 3.1.8 Orientation of the C-domain of basal arrestin and p44 with the 
membrane 
Left: basal arrestin, PDB 1CF1, α conformer, C-edge loops Right: p44 arrestin PDB 4ZJW, 
chain b, C-edge loops. Side chains of the arrestin sites that were labelled with monobromobimane 
197 
334 
344 
342 
339 
271 
271 
229 
230 
339 
342 
344 
334 
197 
230 
229 
Right: Distance maps derived from MD and fluorescence experiments. Sites on the C-edge are 
represented by spheres at the Cα atoms. For the MD derived distances, proximity to the 
phospholipid bilayer (lower panel) or to Carbon 5 on the acyl chain (upper panel) are shown 
using the colour scheme (red being close contact and blue being 20Ȧ away), as seen during the 
simulations. For the fluorescence quenching derived distances, red corresponds to a high level 
of quenching (up to 30%) and blue to low levels of quenching, by N-tempoyl palmitamide on 
the membrane surface (lower panel) and 5-doxyl stearic acid in the membrane interior (upper 
panel). White asterisks correspond to negative quenching values (see main text for details). 
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are shown. Red = residues on the 344-loop: T334, S344, L342, L339, blue = F197 on the 197-
loop, green = residues on the lower C-edge loops: N271, S229, T230.  
 
3.1.7 Conclusions 
The seminal finding of this work is that the C-edge of arrestin serves as a membrane 
anchor and is an important binding element in the arrestin-receptor complex. The 
fluorescence experiments, carried out with arrestin mutants showed a clear association 
between the C-edge of arrestin with the membrane. As the results from the fluorescence 
quenching experiments correlated strongly with the molecular dynamics simulations, it 
signifies that the interaction also occurs with wild type arrestin. Furthermore, as some 
fluorescently labelled sites on the N-domain of arrestin showed no interaction with the 
membrane, and no interaction was observed between arrestin and the membrane in the 
absence of the receptor, it is clear that membrane association is not simply an artefact of 
the presence of the fluorophore on arrestin.  
Notably, the membrane anchor is engaged differently between the pre-complex and the 
high-affinity complex. In the pre-complex only the 344-loop interacts with the membrane, 
with the hydrophobic residues penetrating the hydrophobic layer. This would correspond 
to a C-edge conformation similar to that observed in the “open” crystallographic 
conformer of basal-state arrestin. In the high-affinity complex there is a change in 
orientation in the 344-loop, with residues adjacent to the hydrophobic patch also able to 
penetrate the membrane interior, as well as the 197-loop. This resembles the interaction 
observed by simulating interaction of the C-edge of p44 with the membrane. Hence, the 
membrane anchor likely resembles the C-edge of p44 in the high-affinity complex.    
Mutation of residues on the C-edge of arrestin to alanine have been previously shown to 
correspond to reduced binding to Rh*P (Ostermaier, Peterhans et al. 2014). As the 
membrane anchor of arrestin is not deployed in the absence of the receptor, it acts as a 
specific binding element, possibly functioning to orientate arrestin in the correct 
conformation for fast binding to the receptor. Therefore, these results have identified a 
further functional binding element on arrestin, and the relevance of this will be further 
discussed in the Discussion, Chapter 4.  
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Supplementary Information 
 
Supplementary Figure 3.1.1 Centrifugal pull down assay of arrestin binding to ROS 
membranes 
Binding of 1µM arrestin to 4µM rhodopsin, in the dark and light, and with membranes enriched 
with: MP = methyl palmitate, TP = tempo palmitate, St = stearic acid, 5DS = 5-doxyl stearic 
acid. The black arrows indicate the position of arrestin on the gels, and the red arrows indicate 
the position of rhodopsin.  
Figure taken from Lally CCM, Bauer B, Selent J, Sommer ME. (2017) C-edge Loops of 
Arrestin Function as a Membrane Anchor Nature Communications 8:14258 
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Supplementary table 3.1.1 Fluorescence properties of bimane-labelled arrestin mutants in the presence 
of enriched ROS-P membranes. Fluorescence intensities are normalized to the fluorescence of 1 μM 
unbound arrestin (see Methods for more details). Mean ± standard error is reported. Numbers in brackets 
indicate number of independent measurements. Quenching efficiencies are reported as a percentage. 
Negative wavelength shifts indicate shifts to lower emission wavelength values.  
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domain, 
finger 
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I72B 
0.94 ± 
0.16 (2) 
0.87 ± 0.12 
(2) 
0.85 ± 
0.10 (2) 2.3 
0.90 ± 0.15 (2) 
0.94 ± 
0.16 (2) -4.4 -5 
M75B 
0.89 ± 
0.08 
(2) 
0.86 ± 0.04 
(2) 
0.95 ±  
0  
(2) 
-10.5 
0.86 ±  
0  
(2) 
0.82 ± 
0.01 (2) 4.6  
N-
domain V94B 
1.05 ±  
0  
(2) 
1.02 ±  
0  
(2) 
1.08 ± 
0.03 (2) -5.9 
1.13 ± 0.03 (2) 
1.09 ± 
0.04 (2) 3.5  
N-
domain, 
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loop 
V139B 
0.86 ± 
0.02 (2) 
0.87 ± 0.05 
(2) 
0.87 ±  
0  
(2) 
0 
0.84 ±  
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(2) 
0.72 ± 
0.02 (2) 14.3  
 
N-
domain, 
160 loop 
V159B 
1.08 ± 
0.05 (3)  
1.15 ± 0.03 
(3) 
1.09 ± 
0.10 (3) 5.2 
1.04 ± 0.10 (3) 
1.19 ± 
0.02 (3) -14.4  
E161B 
1.3  
± 0.05 (2) 
1.4 ± 0.2 
(2) 
1.1 ± 0.13 
(2) 21.4 
1.3 ± 0.25 (2) 
1.25 ± 
0.12 (2) 3.8  
K163B 
0.92 ± 
0.10 (2) 
0.98 ± 0.06 
(2)  
0.94 ± 
0.11 (2) 4.1 
0.90 ± 0.09 (2) 
0.87 ± 
0.05 (2) 3.3  
C-
domain, 
197 loop 
F197B 
0.89 ± 
0.03 (2) 
0.94 ±  
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(2) 
0.88 ± 
0.06 (2) 6.4 
0.88 ± 0.05 (2) 
0.81 ± 
0.07 (2) 7.9  
C-
domain, 
229 loop 
S229B 
1.16 ± 
0.04 (2) 
1.02 ± 0.05 
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0.89 ± 0.11 (3) 
1.05 ± 
0.14 (3) -18.0  
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0.70 
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0  
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0.66 ± 
0.05 (3) -13.8  
L339B 
0.99 ± 
0.02 (2) 
1.22 ± 0.09 
(2) 
1.17 ± 
0.07 (2) 4.1 
0.93 ±  
0 
(2) 
0.79 ± 
0.04 (2) 15.0 -5 
L342B 
1.01 ±  
0.2 (2) 
1.13 ± 0.26 
(2) 
1.01 ± 
0.23 (2) 10.6 
0.98 ± 0.21 (2) 
0.69 ± 
0.08 (2) 29.6 -8  
S344B 
0.5  
± 0.07 (2) 
0.58 ± 0.12 
(2) 
0.48 ± 
0.05 (2) 17.2 
0.46 ± 0.02 (2) 
0.51 ± 
0.04 (2) -10.9 -3 
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Light-activated high-affinity complex 
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I72B 
1.66 ± 
0.13 (2) 
1.69 ± 
0.07 (2) 
1.52 ± 
0.12 (2) 10.1 
1.77 ± 0.21 (2) 
1.86 ± 
0.24 (2) -5.1 -27  
M75B 
0.93 ± 
0.07 (2) 
0.95 ± 
0.02 (2) 
0.97 ± 
0.03 (2) -2.1 
0.97 ± 0.02 (2) 
0.95 ± 
0.05 (2) 2.1 -6  
N-
domain V94B 
1.08 ±  
0  
(2) 
1.05 ±  
0  
(2) 
1.12 ± 
0.04 (2) -6.7 
1.23 ± 0.02 (2) 
1.18 ± 
0.04 (2) 4.1  
N-
domain, 
middle 
loop 
V139B 
1.29 ± 
0.02 (2) 
1.15 ± 
0.02 (2) 
1.12 ± 
0.01 (2) 2.6 
1.23 ±  
0  
(2) 
1.18 ± 
0.02 (2) 4.1  
 
N-
domain, 
160 
loop 
V159B 
1.19 ± 
0.06 (3)  
1.30 ± 
0.04 (3) 
1.18 ± 
0.11 (3) 9.2 
1.19 ± 0.11 (3) 
1.38 ± 
0.05 (3) -16.0  
E161B 
1.3 ± 0.08 
(2) 
1.42 ± 
0.15 (2) 
1.15 ± 
0.14 (2) 19.0 
1.31 ± 0.26 (2) 
1.31 ± 
0.12 (2) 0  
K163B 
0.95 ± 
0.10 (2) 
1.01 ± 
0.05 (2) 
0.94 ± 
0.11 (2) 6.9 
0.97 ± 0.09 (2) 
0.96 ± 
0.05 (2) 1.0  
C-
domain, 
197 
loop 
F197B 
1.07 ± 
0.04 (2) 
1.13 ± 
0.02 (2) 
0.87 ± 
0.08 (2) 23.0 
1.11 ± 0.07 (2) 
0.85 ± 
0.11 (2) 23.4 -11  
C-
domain, 
229 
loop 
S229B 
1.28 ± 
0.03 (2) 
1.20 ± 
0.03 (2) 
1.19 ± 
0.02 (2) 0.83 
1.18 ± 0.05 (2) 
1.25 ± 
0.06 (2) -5.9  
T230B 
1.07 ± 
0.14 (3) 
1.06 ± 
0.10 (3) 
0.96 ± 
0.14 (3) 9.4 
1.03 ± 0.14 (3) 
0.98 ± 
0.15 (3) 4.8 -3  
C-
domain, 
C loop 
S251B 
2.8 ± 0.5 
(3) 
2.48 ± 
0.29 (3) 
1.90 ± 
0.16 (3) 23.4 
2.39 ± 0.2 (3) 
1.95 ± 
0.07 (3) 18.4 -5  
C-
domain N271B 
1.01 ± 
0.03 (3) 
1.03 ±  
0  
(3) 
0.95 ± 
0.06 (3) 7.8 
0.98 ± 0.13 (3) 
1.13 ± 
0.11 (3) -15.3  
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344 
loop 
T334B 
0.95 ± 
0.04 (3) 
1.05 ± 
0.06 (3) 
0.92 ±  
0  
(3)  
12.4 0.95 ± 0.04 (3) 
0.93 ± 
0.04 (3) 2.1  
L339B 
1.11 ± 
0.11 (2) 
1.37 ± 
0.08 (2) 
1.0 
± 0.03 (2) 27.0 
1.16 ± 0.11 (2) 
0.95 ± 
0.08 (2) 18.1 -10  
L342B 
1.01 ± 
0.23 (2) 
1.06 ± 
0.21 (2) 
0.73 ± 
0.16 (2) 31.1 
1.03 ± 0.25 (2) 
0.80 ± 
0.12 (2) 22.3 -10  
S344B 
0.78 ± 
0.04 (2) 
0.84 ± 
0.02 (2) 
0.59 ±  
0  
(2) 
29.8 0.78 ± 0.08 (2) 
0.63 ± 
0.05 (2) 19.2 -10  
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3.2 Conformation of arrestin in the pre-complex as compared to the 
high-affinity complex 
 
3.2.1 Introduction 
Arrestin binding to light-activated phosphorylated rhodopsin (Rh*P) occurs in a two-step 
process. First arrestin interacts with the phosphorylated receptor C-terminus in a primarily 
electrostatic interaction termed the pre-complex, which orientates the two proteins for 
subsequent fast transition to the high-affinity complex (Schröder, Pulvermüller et al. 
2002). To date, there is little information in the literature regarding the structure of the 
pre-complex. However, several studies have shown that the C-tail becomes more 
susceptible to proteolysis upon interaction with receptor phosphates, indicating that it 
may be displaced. This effect has also been observed to occur in the presence of the 
polyanionic molecules heparin and IP6, indicating that a negative charge may be 
sufficient for C-tail release. Moreover truncation of the C-tail of arrestin results in a loss 
of specificity of the interaction, and results in a higher binding affinity to Rh* and RhP 
as well as to Rh*P, suggesting that the C-tail acts as an auto-inhibitory element on 
arrestin, and is displaced upon recognition of either the phosphorylation or activation state 
of the receptor, so that arrestin can transition to the high-affinity complex (Palczewski, 
Buczylko et al. 1991, Palczewski, Pulvermüller et al. 1991, Palczewski, Pulvermüller et 
al. 1991, Gurevich, Chen et al. 1994, Zhuang, Vishnivetskiy et al. 2010).  
Crystal structures of active arrestin in complex with a GPCR phosphopeptide (Shukla, 
Manglik et al. 2013), as well as the truncated p44 arrestin variant which lacks the C-tail 
(Kim, Hofmann et al. 2013), provided insights into the conformational changes occurring 
in arrestin upon C-tail displacement. The C-tail makes several contacts within the N-
domain of arrestin, and upon displacement this results in disruption of elements which 
stabilise the basal state of arrestin, in particular the polar core and three element 
interaction. In addition, movement of the gate loop and the central crest loops, and a 21° 
interdomain rotation are observed (Kim, Hofmann et al. 2013, Shukla, Manglik et al. 
2013) (see introduction section 1.3). Displacement of the C-tail has also been observed 
to increase the flexibility of the finger loop, which is located at the arrestin-receptor 
interface, and binds within the active receptor crevice (Hanson, Dawson et al. 2008). 
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3.2.2 Conformation of arrestin in the presence of IP6 
The experiments presented in this section aim to investigate the conformational changes 
occurring in arrestin in both the pre-complex and the high-affinity complex using 
intramolecular quenching, which allows for monitoring of the movement and orientation 
of different sites on arrestin. The initial experiments focussed on determining the extent 
of C-tail displacement upon arrestin interaction with the polyanionic molecule IP6, which 
has previously been shown to bind arrestin and acts as a mimic for the phosphorylated 
receptor C-terminus (Palczewski, Pulvermüller et al. 1991) (Zhuang, Vishnivetskiy et al. 
2010). Several double-arrestin mutants were prepared with one site mutated to a cysteine 
and the other site to a tryptophan in an arrestin construct lacking native cysteines and 
tryptophans. The fluorophore monobromobimane was then covalently-attached to the 
cysteine residue. This approach is based on the ability of tryptophan residues to quench 
the fluorescence of a fluorophore in close proximity. The C-tail of arrestin remains 
unresolved in crystal structures, and so its location in the arrestin structure is not known. 
However, the C-tail contains many acidic residues, and therefore it is possible that it 
resides within the concave surface of the N-domain, which contains a cluster of basic 
residues. In order to test this hypothesis sites 72 and 169 on the N-domain were chosen 
for labelling with monobromobimane, as these are well-characterised and do not interfere 
with arrestin binding when labelled. These sites, as well as the estimated location of the 
tryptophan-substituted sites along the arrestin C-tail are shown in figure 3.2.1. 
 
Along with experiments which monitored C-tail displacement, the effect of IP6 on the 
orientation of the finger loop and gate loop was also investigated using previously 
established mutants containing tryptophan-monobromobimane pairs (Sommer, Farrens et 
al. 2007, Kim, Hofmann et al. 2013) (see figure 3.2.1).  In order to probe displacement of 
the gate loop, the arrestin mutant with monobromobimane attached at site 299, and a 
tryptophan substitution at site 173 (I299B/L173W) was employed. In the basal state of 
arrestin site 299 and 173 are far apart, and therefore no quenching of fluorescence is 
observed, but upon arrestin activation the gate loop moves towards the N-domain, thereby 
bringing the sites into close enough proximity for quenching to occur (Kim, Hofmann et 
al. 2013). In order to probe for changes occurring in the finger loop, the arrestin mutant 
K298B/I72W was employed (Sommer, Farrens et al. 2007). The finger loop is the main 
interaction site in the arrestin-receptor interface, and it adopts an extended conformation 
to bind into the open crevice of the active receptor (Szczepek, Beyriere et al. 2014, Kang, 
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Zhou et al. 2015). In the basal state of arrestin the finger loop is folded down, making 
contact with the N-domain of arrestin (Hirsch, Schubert et al. 1999). However, 
displacement of the arrestin C-tail has been shown to result in increased flexibility in the 
finger loop (Hanson, Dawson et al. 2008), and therefore C-tail displacement could 
correspond to a relief of quenching observed with this arrestin mutant. As phenylalanine 
is a similar size to tryptophan but does not act as a fluorescence quencher, the arrestin 
mutants K298B/I72F and I72B/I299F were also measured to serve as a control.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quantum yield measurements: the C-tail is in close proximity to the fluorophore-
labelled sites on the N-domain, in the basal state of arrestin  
Quantum yield, which is a measure of the proportion of photons emitted as compared to 
the number of photons absorbed by a fluorophore (see section 2.1 for more details) was 
measured for each of the arrestin mutants (supplementary table 3.2.1). These values 
provided the initial indication that the distal C-tail was in close proximity to the 
fluorophores at sites 169 and 72 in the basal state of arrestin, as the quantum yield of the 
Figure 3.2.1 arrestin-1 shown 
with sites labelled with a 
fluorophore or mutated to 
tryptophan 
Sites on arrestin labelled with 
either the fluorophore 
monobromobimane (Cα atoms 
shown as blue spheres), or 
substituted to Tryptophan (Cα 
atoms shown as red spheres).  
Top: Arrestin mutants employed 
to monitor displacement of the C-
tail. Sites 72 and 169 on the N 
domain were labelled with 
monobromobimane, and 6 sites 
on the C tail (Y391W, E393W, 
T296W, Q398W, A400W and 
M402W were individually 
mutated to Tryptophan.  
Bottom: Arrestin mutants 
employed to measure movement 
of the gate loop (I299B/L173W), 
and the finger loop 
(K298B/I72W) 
 
See main text for more details 
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fluorophore at these sites was lower in all arrestin mutants containing tryptophan 
substitutions on the C-tail.  In particular, substitution of sites on the most distal portion of 
the C-tail (T296W, Q398W, A400W and M402W) had the largest effect on the quantum 
yield of the fluorophore at site 72, and similarly substitutions A400W and M402W 
decreased the quantum yield of the fluorophore at site 169.   
As expected, the fluorophore-tryptophan pair K298B/I72W reported a decrease in 
quantum yield as compared to the phenylalanine control, indicative that the finger loop is 
sufficiently close to the interdomain interface for quenching to occur in unbound arrestin. 
The fluorophore-tryptophan pair I299B/L173W reported no significant decrease in 
quantum yield as compared to the phenylalanine control, which is consistent with the 
distance between these sites in the unbound arrestin conformation.  
Fluorescence lifetime measurements and quenching analysis 
Fluorescence lifetimes were determined for each of the arrestin mutants both in the 
unbound state in low salt conditions, and in the presence of IP6 (see supplementary tables 
3.2.2, and 3.2.3, respectively). The lifetimes were analysed using FluoFit software (from 
Picoquant GmbH), which plotted the log of intensity decay (log I (t)) against time (t) 
using reconvoluted curve fitting algorithms, and calculated the lifetimes using χ2 analysis 
to determine the best fit (see figure 3.2.2). The IRF (see section 2.2.10), is shown in red. 
As there were three lifetimes derived from the fit, the amplitude weighted lifetime was 
used as the average fluorescent lifetime for each of the mutants (see methods chapter, 
section 2.2.10).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.2 
Example 
reconvolution 
curve showing the 
decay in 
fluorescence 
intensity over time  
Top: The IRF is 
shown in red, and the 
reconvolution decay 
curve is shown in 
blue. The fit yielded 
three fluorescence 
lifetimes, with a χ2 of 
0.995, indicating a 
strong fit. 
Bottom: Plot of the 
residuals of the fit.  
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The quantum yield and the amplitude weighted lifetime mesaured for each of the arrestin 
mutants was used to analyse the type of quenching occuring using the equations described 
in the methods chapter, section 2.2.10. The quenching analysis is shown in figure 3.2.3. 
For each mutant the relative proportions of unquenched, dynamically quenched and 
statically quenched fluorphores could be determined. The analysis provided more 
information about the proximity and flexibility of the loops containing the fluorophore 
and the trytophan quencher (see section 2.1 for more details on quenching). 
 
# 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.3: Quenching profile of each of the arrestin mutants in the presence and 
absence of IP6 
Quenching was determined for each of the mutants in the presence (+) and absence (-) of 
2.5mM IP6 in 50mM Hepes pH 7 buffer. The fraction of each quenching component was 
calculated (see methods 2.2.10). Blue = unquenched fluorophores, Red = dynamic quenching 
and Black = static quenching.   
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Only the distal portion of the C-tail is displaced in the presence of IP6 
Fluorescence quenching was calculated in the presence and absence of IP6 (see figure 
3.2.3 and table 3.2.1). In the absence of IP6 quenching of the monobromobimane 
fluorophore was observed by tryptophan residues at all points tested along the C-tail, with 
the most quenching observed with mutants I72B/T396W, I72B/Q398W and 
I72B/A400W, as well as S169B/A400W and S169B/M402W. Most of the quenching 
observed was static quenching, although the mutant S169B/M402W reported similar 
levels of static and dynamic quenching. The presence of IP6 yielded very interesting 
results. For mutants I72B/Y391W and I72B/E393W there was a very small reduction in 
the quenching efficiency. However, at sites I72B/T396W, I72B/Q398W I72B/A400W, 
S169B/A400W and S169B/M402W the quenching was almost completely disrupted. 
This difference in quenching profile indicates that release of the C-tail in the presence of 
a negatively charged species displaces only the terminal portion of the C-tail, with sites 
391 and 393 remaining in contact with the N-domain.  
The gate loop and finger loop are unaffected by IP6 
Very little quenching was observed with the arrestin mutant I299B/L173W in the 
presence of IP6 indicating that IP6 does not induce any movement of the gate loop. The 
arrestin mutant K298B/I72W reported a similar level of quenching in both the presence 
and absence of IP6, indicating that the finger-loop is in a folded down conformation (see 
figure 3.2.3 and table 3.2.1).  
Overall these quenching results indicate that the presence of IP6 does displace the C-tail, 
but importantly, only the distal portion. The proximal portion of the C-tail remains 
unchanged by the presence of IP6. As this proximal region of the C-tail comprises part of 
the gate loop, and forms part of the polar core and three-element interaction (See 
Introduction chapter, section 1.3), activation of arrestin only occurs when this portion is 
displaced. This correlates well with the quenching reported for the gate loop and finger 
loop, which indicates that displacement of the distal C-tail in the presence of IP6 does not 
induce movement within these regions on arrestin.   
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Table 3.2.1 Percentage of unquenched, statically quenched and 
dynamically quenched fluorophores calculated for each of the 
arrestin mutants in low salt buffer and in the presence of 2.5mM 
IP6.  
 % Non-
quenched 
% static 
quenching 
% dynamic 
quenching 
Mutant No 
salt 
+IP6 No salt +IP6 No salt +IP6 
I72B 
Y391W 
80 88 22 10 -2 2 
I72B 
E393W 
70 82 29 17 1 0 
I72B 
T396W 
49 104 42 -5 9 1 
I72B 
Q398W 
44 104 52 -5 4 2 
I72B 
A400W 
53 100 39 -8 8 8 
       
S169B 
A400W 
67 95 25 4 9 1 
S169B 
M402W 
63 99 23 -3 14 4 
       
K298B 
I72W 
43 43 44 47 13 10 
       
I299B 
L173W 
97 97 4 0 -1 2 
 
3.2.3 Conformation of arrestin in complex with phosphorylated opsin.  
Opsin arises in the rod cell when all-trans-retinal moves out of the binding pocket of 
active rhodopsin (Rh*). Arrestin remains bound to phosphorylated Opsin (OpsP) until 
regeneration with 11-cis-retinal reforms RhP. The conformation of phosphorylated opsin 
exists in an equilibrium between OpsP, which has a conformation similar to inactive 
rhodopsin, and Ops*P, which has a similar conformation to Rh*P. Under physiological 
conditions this equilibrium favours OpsP, with very low amounts of Ops*P present in the 
rod cell. However, it has previously been shown that the equilibrium is pH dependent: 
more Ops*P is present at lower pHs and more OpsP is present at higher pHs (Vogel and 
Siebert 2001) (see figure 3.2.4). As Opsin contains no retinal (which as an absorptive 
molecule can interfere with the fluorescence signal), fluorescence experiments measuring 
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arrestin binding to Opsin at different pHs serve as a useful tool to monitor the 
conformation of arrestin in the pre-complex and the high-affinity complex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to investigate the conformation of arrestin in the pre-complex as compared to the 
high-affinity complex, the fluorescence of labelled arrestin mutants was measured in the 
presence of phosphorylated opsin at three different pHs: pH 6 (with the active opsin 
conformation favoured), pH 7 (with a mixture of active and inactive opsin conformations) 
and pH 8 (with the inactive conformation favoured). The arrestin mutants employed were 
I72NBD, which is sensitive to the activation state of the receptor, F197NBD, which 
reports on membrane anchoring in the high-affinity complex only, I299B/L173W, which 
monitors movement of the gate loop, and S251B, which reports on interdomain rotation 
upon arrestin activation.  
Figure 3.2.4  
Schematic of the 
conformational 
equilibrium of 
opsin  
At higher pHs the 
inactive conformation 
of opsin is favoured, 
whereas the active 
conformation is 
favoured at higher 
pHs.    
 
Figure 3.2.5 Sites 
on arrestin-1 
labelled with a 
fluorophore or 
substituted to 
tryptophan 
The Cα atoms of sites 
on arrestin labelled 
with a fluorophore are 
shown as blue 
spheres, and 
substituted to 
tryptophan are shown 
as red spheres) 
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The fluorescence changes occurring at fluorophores on the finger loop and the 197-loop 
demonstrated that arrestin binding to opsin at pH 8 resembles the pre-complex, and at pH 
6 resembles the high-affinity complex.  
The fluorescence at site 72 on the finger loop reports an increase and blue-shift in 
fluorescence intensity upon formation of the high-affinity complex, due the site being 
embedded within the active receptor crevice. The fluorescence spectra in the presence of 
opsin (figure 3.2.6) show a fluorescence intensity at pH 6 comparable to that observed 
with Rh*P, indicating that the finger loop binds within the active helical core of active 
opsin as well as Rh*P. At pH 7 the fluorescence intensity upon binding opsin is lower, 
and at pH 8 the fluorescence intensity is only slightly higher than unbound arrestin. Pull-
down assays showed comparable arrestin binding to the receptor in all conditions, which 
confirm that the fluorescence changes are as a result of the finger loop engaging the active 
receptor at pH 6, but not at pH 8.  
The fluorophore at site 197 reports an increase in fluorescence intensity when bound to 
Rh*P as a result of this site penetrating the membrane interior (see section 3.1). The 
fluorescence at this site similarly changed when bound to phosphorylated opsin at the 
three different pHs (see figure 3.2.7). When bound to Opsin at pH 6, the fluorescence 
intensity reported was higher, indicative of the membrane anchoring which occurs at this 
site in the high-affinity complex. The fluorescence intensity at pH 7 was lower, and when 
bound to opsin at pH 8 there was only a small fluorescence increase as compared to 
unbound arrestin, which is indicative of the orientation of this site in the pre-complex, 
where no membrane association occurs (see section 3.1).   
 
Arrestin is only activated in the presence of the helical crevice of the active receptor 
The fluorescence changes in arrestin mutants monitoring movement of the gate loop and 
interdomain rotation, provided information about the conformation of arrestin when 
bound in the pre-complex to inactive opsin at pH 8, and in the high-affinity complex to 
active opsin at pH 6.  
The fluorescence intensity of the arrestin mutant I299B/L173W is sensitive to movement 
of the gate loop. In the basal state of arrestin the gate loop comprises part of the polar 
core and the two sites are far apart. Upon arrestin activation, the polar core is disrupted, 
and movement of the gate loop brings the sites into close enough proximity for quenching 
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to occur, resulting in a decrease in fluorescence intensity. The fluorescence spectra shown 
for this mutant (figure 3.2.6) shows that the decrease in fluorescence intensity as 
compared to unbound arrestin, is similar when bound to opsin at pH 6 and Rh*P, 
indicating arrestin is in an active conformation. The fluorescence intensity when bound 
to opsin at pH 7 and pH 8 is higher, although pull-down assays show that arrestin is bound 
to opsin in all conditions. This indicated that arrestin bound to opsin in the absence of the 
active helical core, remains in a basal conformation with the polar core intact.   
The arrestin mutant S251B reports on the interdomain rotation that occurs upon arrestin 
activation. In the basal conformation of arrestin the fluorophore at site 251 is quenched 
by a neighbouring tyrosine (Y61) residue, with both sites comprising part of the 
YKS(N)D(A) hydrogen bond network, which binds the base of the finger loop to the C-
loop and stabilises the interdomain interface. Upon arrestin activation this hydrogen bond 
network is disrupted, which results in an interdomain rotation of the two domains relative 
to each other. The two sites are no longer in close enough proximity for quenching to 
occur, which corresponds to an observed increase in fluorescence at a fluorophore placed 
at site 251 (Kim, Hofmann et al. 2013). The fluorescence at site 251 when bound to opsin 
at the three different pHs is shown in figure 3.2.7. At pH 6, in the presence of the active 
receptor helical core, there is a large increase in fluorescence as compared to unbound 
arrestin, indicative of the interdomain rotation which occurs with arrestin activation. 
However, when bound to opsin at pH 8, there is a smaller increase in fluorescence, 
indicating that arrestin bound to the inactive receptor in the pre-complex is in a basal 
conformation, with respect to interdomain rotation. 
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Figure 3.2.6 Steady-state fluorescence spectra of arrestin mutants bound to 
Rh*P and OpsP at different pHs.  
Top: fluorescence spectra of 2µM arrestin mutants a)  I72NBD and c) I299B/L173W. grey = 
unbound arrestin, black dashed line = arrestin bound to Rh*P, red = arrestin bound to 
OpsP at pH 6, green = arrestin bound to OpsP at pH 7, blue = arrestin bound to OpsP at 
pH 8.  
Bottom: SDS gels showing the amount of arrestin bound using the pull-down assay, for 
arrestin mutants b) I72NBD and d) I299B/L173W. Lane 1 = arrestin binding to Rh*P, lane 
2 = arrestin binding to opsin at pH 6, lane 3 = arrestin binding to opsin at pH 7, lane 4 = 
arrestin binding to opsin at pH 8, lane 5 = negative control showing no arrestin is bound to 
Rh*P in the presence of 5M NaCl, lane 6 = positive control showing the amount of arrestin 
present in each of the samples. 
Figure published in “Functional map of arrestin binding to phosphorylated opsin, with and 
without agonist” Peterhans C., Lally C.C.M., Ostermaier M.K., Sommer M.E., Standfuss J. 
Scientific Reports 6:28686. 
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3.2.4 Conclusions 
Overall the quenching results show information about the conformation of arrestin when 
bound to IP6, as well as to the phosphorylated receptor C-terminus, in both the presence 
and absence of the active helical core of the receptor.   
Arrestin remains in a basal conformation in the pre-complex  
In the pre-complex arrestin is bound to the inactive phosphorylated receptor, through 
interaction with the receptor phosphates. It had previously been proposed that receptor 
phosphates, or a negatively charged species such as IP6 or heparin, could displace the 
auto-inhibitory arrestin C-tail. However, the results presented in this section demonstrate 
that only the distal portion of the C-tail is displaced in the absence of an active receptor 
species. IP6 was found to displace the C-tail as far as site 396, but site 393 remained in 
contact with the arrestin N-domain. As this proximal portion of the C-tail remained in 
contact with the N-domain of arrestin, the gate loop and finger loop did not undergo any 
movement in the presence of IP6. Similarly the presence of OpsP at pH 8 which favours 
the inactive form of the receptor did not induce any activating conformational changes in 
most of the arrestin population: The gate loop remained in its basal conformation, the C-
edge membrane anchor was not engaged, and there was no interdomain rotation observed. 
2µM S251B with 6µM Opsin at different pHs
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X Data
420 440 460 480 500 520 540 560 580 600
Y
 D
a
ta
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
Col 1 vs buf 
Col 1 vs ops6 
Col 1 vs ops7.5 
Col 1 vs ops8.5 
2µM F197NBD with 6µM Opsin at different pHs
50mM Hepes buffer
X Data
520 540 560 580 600 620 640 660 680 700
Y
 D
a
ta
0
10000
20000
30000
40000
50000
60000
70000
Col 1 vs buf 
Col 1 vs ops6 
Col 1 vs ops7.5 
Col 1 vs ops8.5 
Wavelength (nm) 
(nm) 
 
 
4 
8 
12 
16 
S251B 
OpsP pH 7 
Unbound 
Arrestin 
 
0 
 
 
60 
Wavelength (nm) 
(nm) 
Fl
u
o
re
sc
en
ce
 C
P
S 
(*
1
0
00
) 
F197NBD 
Unbound 
Arrestin 
OpsP pH 6 
OpsP pH 7 
OpsP pH 8 
Figure 3.2.7 Steady-state fluorescence spectra of arrestin mutants bound to OpsP 
at different pHs 
Fluorescence spectra of 2µM labelled arrestin mutants left: F197NBD and right: S251B. 
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Therefore, it can be deduced that in the pre-complex interaction with the phosphorylated 
receptor C-terminus, arrestin likely remains in a basal conformation with just the terminal 
8-11 C-tail residues displaced.  
Arrestin adopts an active conformation in the presence of the active receptor 
In the presence of OpsP at pH6, most of the opsin is in an active conformation (Ops*P), 
and this is correlated to changes in the conformation of arrestin: the finger-loop is 
embedded within the active helical core of the receptor, there is movement of the gate 
loop, interdomain rotation, and engagement of the C-edge membrane anchor. All of these 
structural changes are observed in the active conformation of arrestin when bound in the 
high-affinity complex (Kang, Zhou et al. 2015), and in the p44 crystal structure (Kim, 
Hofmann et al. 2013). Therefore, it is likely that interaction with the active receptor is 
required for full displacement of the arrestin C-tail, which allows for the subsequent 
interdomain rotation, and an active arrestin conformation.     
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Supplementary Information 
Supplementary Table 3.2.1 Fluorescence properties of monobromobimane-labelled arrestin 
mutants 
Mutant 
Absorbance 
λmax (nm) 
Emission 
λmax (nm) 
Estimated ϕ, 
low salt 
Estimated ϕ, 
With IP6 
Average 
‹τ› (ns) 
I72B 390 480 0.20 0.17 8.51 
I72B Y391W 390 480 0.16 0.15 8.69 
I72B E393W 392 480 0.14 0.14 8.37 
I72B T396W 394 480 0.098 0.176 7.21 
I72B Q398W 394 480 0.088 0.176 7.75 
I72B A400W 392 480 0.106 0.17 7.39 
 
S169B 385 480 0.27 0.284 10.35 
S169B A400W 387 480 0.18 0.27 9.15 
S169B M402W 387 480 0.17 0.28 8.44 
 
K298B I72F 390 480 0.2 0.21 9.24 
K298B I72W 395 480 0.094 0.09 7.08 
 
I299B L173F 389 468 0.39 0.39 13.98 
I299B L173W 389 468 0.38 0.38 14.18 
λmax, wavelength of maximal absorbance or emission 
ϕ, quantum yield, measured in isotonic buffer (50 mM HEPES pH 7, 130 mM NaCl). Quantum 
yield in low salt buffer and 2.5mM IP6 were determined through titration curves of NaCl and IP6, 
respectively (see methods section 2.2.10). 
‹τ› = α1τ1 + α2τ2 + α3τ3, the amplitude weighted average fluorescence lifetime. The average 
amplitude weighted fluorescence lifetime was calculated from three different repeats for each 
mutant (see supplementary table 3.2.2). 
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Supplementary table 3.2.2 Fluorescence lifetime data under low-salt conditions  
 Fractional amplitude of positive decay components   
Mutant α1 τ1 (ns) α2 τ2 (ns) α3 τ3 (ns) 
Amplitude-
weighted 
average 
lifetime 
(ns) 
χ2 
I72B 
0.20 0.56 0.31 5.74 0.50 13.14 8.4004 0.991 
0.16 0.9 0.48 7.3 0.36 14.22 8.783 1.035 
0.02 0.84 0.45 7.19 0.36 13.95 8.3479 0.878 
I72B 
Y391W 
0.15 1.19 0.35 6.11 0.50 13.25 8.924 1.022 
0.18 1.52 0.52 8.31 0.29 15.31 9.106 0.966 
0.23 0.63 0.45 7.28 0.32 14.45 8.0368 0.910 
I72B 
E393W 
0.16 0.87 0.34 5.97 0.50 13.67 9.0429 1.034 
0.21 0.85 0.49 7.04 0.30 14.39 7.973 1.061 
0.23 0.66 0.46 7.32 0.31 14.72 8.1022 0.919 
I72B 
T396W 
0.24 0.77 0.37 5.22 0.39 12.57 7.0024 1.112 
0.25 1.75 0.55 7.83 0.20 15.27 7.759 0.938 
0.27 0.74 0.45 6.47 0.28 13.52 6.8684 0.892 
I72B 
Q398W 
0.21 0.84 0.39 5.46 0.39 13.21 7.4994 0.995 
0.24 1.46 0.53 7.67 0.23 15.67 8.037 0.943 
0.24 1.08 0.49 7.10 0.27 14.74 7.7017 1.004 
I72B 
A400W 
0.20 1.14 0.50 6.71 0.30 14.18 7.877 0.957 
0.24 0.77 0.46 6.43 0.31 13.55 7.2546 0.960 
0.25 0.75 0.45 6.40 0.30 13.3 7.0287 0.947 
 
 
 
S169B 
0.09 1.81 0.52 9.30 0.39 16.84 11.566 1.005 
0.19 0.55 0.39 8.16 0.42 16.18 10.0410 0.951 
0.22 0.46 0.40 8.26 0.38 15.9 9.4466 0.951 
S169B 
A400W 
0.18 1..76 0.49 8.6 0.33 16.3 9.932 0.937 
0.25 0.58 0.39 7.10 0.37 15.43 8.5622 0.972 
0.21 0.67 0.43 7.43 0.36 15.6 8.9510 0.930 
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S169B 
M402W 
0.19 1.20 0.47 7.52 0.35 15.29 9.037 0.953 
0.28 0.50 0.38 6.88 0.34 15.13 7.9268 0.966 
0.24 0.61 0.41 7.05 0.35 15.15 8.3529 0.979 
 
 
K298B 
I72F 
0.17 0.81 0.40 5.94 0.43 15.47 9.1756 0.980 
0.18 1.22 0.54 8.09 0.28 18.02 9.685 1.004 
0.22 0.76 0.50 7.54 0.28 17.47 8.8735 0.961 
K298B 
I72W 
0.23 0.91 0.41 5.57 0.36 13.41 7.2700 1.019 
0.22 1.07 0.52 6.60 0.26 14.77 7.508 0.944 
0.29 0.56 0.45 5.89 0.26 14.06 6.4667 1.005 
 
 
I299B 
L173F 
0.24 1.06 0.59 14.38 0.17 27.15 13.298 1.263 
0.17 2.75 0.43 11.26 0.41 22.36 14.330 0.950 
0.18 1.18 0.38 10.99 0.44 22.39 14.309 1.016 
I299B 
L173W 
0.20 2.44 0.63 15.00 0.17 28.41 14.818 1.118 
0.24 1.60 0.36 9.38 0.40 21.77 12.503 0.986 
0.16 1.84 0.40 12.04 0.4 22.89 15.228 1.051 
τ = lifetime 
α = proportion of fluorophores with lifetime, τ 
χ2 = statistical robustness of the fit 
Repeats are shown for each mutant 
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Supplementary table 3.2.3 Fluorescence lifetime data in the presence of 2.5mM IP6  
 Fractional amplitude of positive decay components   
Mutant α1 τ1 (ns) α2 τ2 (ns) α3 τ3 (ns) 
Amplitude-
weighted 
average 
lifetime 
(ns) 
χ2 
I72B 
0.12 0.75 0.29 4.94 0.59 12.05 8.621 1.033 
0.15 1.76 0.55 8.25 0.30 14.96 9.309 1.013 
0.22 0.54 0.37 6.32 0.41 12.53 7.5756 0.911 
I72B 
Y391W 
0.18 0.54 0.31 5.01 0.51 12.24 7.942 1.045 
0.16 1.41 0.52 8.01 0.32 14.18 8.935 0.941 
0.21 0.76 0.46 7.46 0.33 13.62 8.1313 0.942 
I72B 
E393W 
0.16 1.02 0.34 6.66 0.51 13.00 8.9957 1.028 
0.17 1.28 0.49 7.38 0.34 13.45 8.431 0.962 
0.22 0.61 0.44 7.39 0.34 13.65 7.9911 0.968 
I72B 
T396W 
0.14 0.72 0.31 5.43 0.55 12.03 8.3894 0.984 
0.16 1.20 0.52 7.59 0.32 13.71 8.505 0.922 
0.21 1.52 0.61 8.75 0.18 14.91 8.3333 1.005 
I72B 
Q398W 
0.16 0.78 0.31 5.59 0.53 12.28 8.3841 1.012 
0.16 1.33 0.53 7.93 0.31 14.19 8.844 0.959 
0.22 0.63 0.42 7.01 0.36 13.26 7.8745 0.946 
I72B 
A400W 
0.18 1.70 0.49 7.93 0.32 13.67 8.669 0.993 
0.23 0.56 0.36 6.28 0.41 12.52 7.5438 0.905 
0.24 0.57 0.37 6.33 0.39 12.31 7.3190 0.959 
     
 
 
   
S169B 
0.10 1.79 0.43 9.34 0.47 17.13 11.802 1.024 
0.16 0.69 0.39 8.63 0.45 16.8 11.085 1.066 
0.17 0.58 0.38 8.49 0.45 16.3 10.6248 0.913 
S169B 
A400W 
0.10 1.80 0.49 10.03 0.41 17.49 12.225 0.992 
0.20 0.46 0.34 7.91 0.46 16.37 10.333 0.909 
0.18 0.55 0.37 8.35 0.46 16.23 10.5536 0.972 
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S169B 
M402W 
0.10 1.82 0.44 9.32 0.46 16.97 12.0893 1.010 
0.19 0.56 0.36 8.33 0.45 16.45 10.558 0.939 
0.24 0.4 0.35 8.27 0.41 16.27 9.6990 0.928 
 
 
 
K298B 
I72F 
0.15 1.75 0.56 8.63 0.29 17.60 10.252 0.944 
0.19 0.84 0.51 7.79 0.29 16.89 9.113 0.958 
K298B 
I72W 
0.21 1.55 0.48 7.63 0.31 15.35 8.771 0.877 
0.28 0.50 0.40 6.08 0.31 14.0 6.9842 0.998 
 
 
I299B 
L173F 
0.15 1.92 0.38 9.77 0.48 21.9 14.392 0.973 
0.14 1.53 0.39 11.50 0.47 22.45 15.271 1.016 
I299B 
L173W 
0.18 2.46 0.34 10.07 0.47 21.58 14.105 0.955 
0.16 1.13 0.33 11.12 0.51 21.9 15.040 1.044 
τ = lifetime 
α = proportion of fluorophores with lifetime, τ 
χ2 = statistical robustness of the fit 
Repeats are shown for each mutant 
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3.3 Different binding stoichiometries of the arrestin-rhodopsin complex 
 
3.3.1 Introduction 
Research in the literature has reported different stoichiometries for the arrestin-rhodopsin 
complex, with evidence for both one-to-one and a one-to-two interactions being reported. 
Evidence for a one-to-one interaction has been obtained through biochemical binding 
assays between arrestin and rhodopsin monomers reconstituted into nanodiscs (Bayburt, 
Vishnivetskiy et al. 2011). These assays observed a comparable binding affinity to that 
of arrestin bound to rhodopsin in native disc membranes. Although these assays do not 
occlude the possibility of a higher stoichiometry, they nonetheless confirmed that a one-
to-one interaction was functional. Furthermore, experiments monitoring binding of 
arrestin by the Extra-Meta-II assay (see methods chapter, section 2.2.4), found that 
stabilisation of the active Meta-II (Rh*P) form of rhodopsin by arrestin was found to 
saturate at a one-to-one stoichiometry (Schleicher, Kühn et al. 1989, Pulvermüller, 
Maretzki et al. 1997). The recently published crystal structure of the Ops*/arrestin-1 
complex (Kang, Zhou et al. 2015) also supports a one-to-one interaction, as the structure 
obtained was of one arrestin bound to one Ops*.  
The proposal for a one-to-two interaction of arrestin-rhodopsin initially arose based on 
the dimensions of the two proteins.  Arrestin has a diameter almost double that of 
rhodopsin, and therefore it was speculated that each of the domains on arrestin could 
interact with a receptor molecule (Modzelewska, Filipek et al. 2006). Evidence for a one-
to-two interaction have arisen from titration analyses using biophysical methods to 
measure arrestin binding to rhodopsin, which have identified possible factors which 
influence the stoichiometry, described below.  
1. Photo-activation density of rhodopsin  
Arrestin binding to rhodopsin in native disc membranes containing differing 
percentages of light-activated receptors was measured using different biophysical 
methods (Sommer, Hofmann et al. 2011). The stoichiometry of the interaction 
was found to be dependent on the photo-activation density. At low photo-
activation densities titration analysis indicated a stoichiometry of one-to-one, 
whereas at high photo-activation densities the measured stoichiometry saturated 
at one arrestin for every two Rh*P. The authors speculated two possible 
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explanations for the change in interaction stoichiometry. Firstly, it could arise 
from lack of space on the membrane. In native ROS membranes there is a high 
concentration of rhodopsin molecules, and therefore at high photo-activation 
density steric hindrance could result in arrestin being unable to bind to every 
active receptor. This explanation fits well with in vivo data measuring the 
translocation of arrestin to the rod outer segment (ROS) in transgenic mice 
(Hanson, Gurevich et al. 2007). This study found that when rhodopsin was 
expressed at a higher level, the ratio of arrestin to rhodopsin was lower than when 
less rhodopsin was expressed. The second explanation provided was that the one-
to-two interaction resulted from each of the two domains of arrestin being able to 
interact with a receptor molecule. A follow up study looking into this possibility 
(Sommer, Hofmann et al. 2012) monitored the fluorescence changes occurring at 
a site on the finger loop, as well as the 344-loop, upon arrestin binding to either 
the phosphorylated light-activated receptor (Rh*P), or the phosphorylated 
aporeceptor (OpsP). The fluorescence changes reported that the finger loop was 
only engaged in the presence of the active receptor (Rh*P). The fluorescence 
changes occurring at the site on the 344-loop, on the other hand, correlated to the 
amount of arrestin bound, irrespective of the receptor state (Rh*P or OpsP). A 
model was therefore proposed whereby the finger loop interacted with Rh*P in a 
high-affinity interaction with the active receptor crevice, whereas the 344-loop 
could bind either a neighbouring receptor (which would give rise to a one-to-two 
stoichiometry) or the membrane (which would give rise to a one-to-one 
stoichiometry).  
2. Phosphorylation level of rhodopsin 
Titration analyses from centrifugal pull-down assays described above measuring 
arrestin binding to Rh*P at full photo-activation density, initially reported a 
stoichiometry of one-to-two (Sommer, Hofmann et al. 2011) as compared to a 
stoichiometry of one arrestin molecule to 1.4 rhodopsin molecules in the 
subsequent study (Sommer, Hofmann et al. 2012),   indicating a mixture of one-
to-one and one-to-two stoichiometries in the sample. The difference in binding 
stoichiometry reported in the two studies was attributed to the phosphorylation 
level of rhodopsin used in the studies. The sample preparation protocol to yield 
phosphorylated rhodopsin (see methods chapter, section 2.2.2), had been 
optimised for the second study, thereby resulting in a higher phosphorylation 
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level. Therefore, this suggested a correlation between arrestin interaction with the 
phosphorylated C-terminus and the final binding stoichiometry.  
3. Formation of the pre-complex 
The interaction of arrestin with the phosphorylated receptor C-terminus is termed 
the pre-complex, which is thought to be the initial binding step, before 
transitioning of arrestin into the high-affinity complex with Rh*P (Schröder, 
Pulvermüller et al. 2002).. The C-terminus of rhodopsin contains seven 
phosphorylation sites, even though it has been shown that just three are required 
for high-affinity binding to Rh*P (Vishnivetskiy, Raman et al. 2007). However, 
it is conceivable that higher levels of phosphorylation of the receptor C-terminus 
affect formation of the pre-complex. The results presented in this section 
investigate the effect of pre-complex formation on the final binding stoichiometry 
of the high-affinity complex. As the pre-complex is a primarily electrostatic 
interaction, its stability is adversely affected by salt. Therefore, by modulating the 
salt concentration and carrying out binding titration assays, the correlation 
between pre-complex formation and the stoichiometry of the light-activated high-
affinity complex could be investigated.  
 
3.3.2 Salt sensitivity of arrestin binding to RhP and Rh*P 
Pull down assays which monitor the amount of arrestin bound to the receptor were carried 
out with fluorescently-labelled arrestin at different concentrations of NaCl. Initial binding 
experiments were carried out with arrestin labelled with the fluorophore N,N’-Dimethyl-
N-(Iodoacetyl)-N’-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl=Ethylenediamine (NBD) at site 
366 (A366NBD). This site is on the backside of arrestin, away from the arrestin-receptor 
binding interface, and therefore reports the amount of arrestin bound to rhodopsin under 
different conditions.  
97 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The binding assays shown in figure 3.3.1 showed that almost all of the arrestin present in 
the sample was fully bound to rhodopsin in both the pre-complex and the high-affinity 
complex in the absence of NaCl. The high-affinity complex was less salt sensitive, with 
an IC50 value of 997mM NaCl, as compared to the pre-complex which had an IC50 value 
of 191mM NaCl. The NaCl titrations allowed for conditions to be chosen to monitor 
arrestin binding to rhodopsin in conditions which favour or abrogate the pre-complex. 
Measurements were carried out with either no NaCl added, in which case the amount of 
arrestin bound to RhP and Rh*P were comparable, as well as with 300mM NaCl added, 
in which case the high-affinity complex is unaffected, whereas there is little binding in 
the pre-complex.  
 
3.3.3 Effect of pre-complex formation on the final stoichiometry of the high-affinity 
complex 
Both receptor and arrestin titrations were carried out (figure 3.3.2), as they provide 
different information about binding. The receptor titration reported that all of the arrestin 
was functional and able to bind the receptor, as all of the arrestin present in the sample 
was able to be pulled down by an excess of receptor. The arrestin titration provides a clear 
insight into the stoichiometry of the interaction, as it reports the maximal amount of 
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Figure 3.3.1 Salt sensitivity 
curve for the arrestin - 
receptor complex, with dark 
state (red) and light-activated 
(black) rhodopsin. A centrifugal 
pull down assay with 2µM 
arrestin A366NBD and 8µM 
receptor was carried out at 
different salt concentrations, and 
the amount of arrestin pulled 
down was determined by UV-
vis-spectrometry.    The high-
affinity complex is more 
resistant to salt than the pre-
complex. 
   
  
Arrestin binding to light-
activated Rh*P 
Arrestin binding to dark-
state RhP 
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arrestin that can bind to a given amount of rhodopsin. Arrestin titrations are also less 
prone to measurement error due to scattering by membranes. The Kd of arrestin binding 
and stoichiometry of the interaction calculated for each of the arrestin titrations and 
receptor titrations (binding to RhP and Rh*P in low salt and 300mM NaCl conditions) 
are shown in table 3.3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.2 Centrifugal pull down assays in the dark (pre-complex) and after 
light-activation (high-affinity complex) in conditions favouring and abrogating 
formation of the pre-complex 
Top: Arrestin titrations against 4µM Receptor. Arrestin binding was measured by centrifugal 
pull-down using the labelled arrestin mutant A366NBD, where the concentration of arrestin 
remaining in the supernatant was determined by UV-vis spectroscopy in the presence of low salt 
(black) or 300mM NaCl (red). graph a is after photo-activation, and graph b measures binding 
in the dark.  
Bottom: Receptor titration against 4µM of the labelled arrestin mutant A366NBD, also using 
the centrifugal pull down assay with low salt (black) or with 300mM NaCl (red). graph c is 
after photo-activation, and graph d is in the dark. Points represent multiple experiments. 
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Table 3.3.1 Kd values and binding stoichiometry of A366NBD arrestin bound 
to dark-state RhP and light-activated Rh*P in low salt conditions, and in the 
presence of 300mM NaCl 
  Dark 
RhP, low 
salt 
Dark 
RhP, 
300mM 
NaCl 
Light-
activated 
Rh*P, low 
salt 
Light-
activated 
Rh*P, 
300mM 
NaCl 
Arrestin 
titration 
Apparent Kd 
(µM) 
0.993 n.d. 0.206 0.4 
Stoichiometry 1 : 0.9 n.d. 1 : 0.9 1 : 1.5 
Receptor 
titration 
Apparent Kd 
(µM) 
0.796 n.d 0.203 0.4 
Stoichiometry 1 : 1.4 n.d 1 : 1.1 1 : 1.7 
 
The Kd values calculated in low salt conditions for arrestin binding to Rh*P report values 
of 206nM and 203nM for the arrestin and receptor titrations respectively, and arrestin 
binding to RhP reported a Kd of 993nM and 796nM for the arrestin titrations and receptor 
titrations, respectively. These values are similar to the values reported previously using 
the centrifugal pull-down method (Sommer, Hofmann et al. 2011). The stoichiometry of 
the interaction, as determined from the arrestin titration curves was shown to be sensitive 
to the formation of the pre-complex, as explained below.  
 In the absence of NaCl each arrestin binds one rhodopsin molecule 
The stoichiometry of the interaction as determined by the arrestin titrations in the absence 
of salt is 1 arrestin to 0.9 receptor, for both the pre-complex and the high-affinity complex 
(graphs a and b, black circles). All arrestin present in the sample was bound to the ROS 
membranes in the dark in the absence of NaCl, (graph d, black circles) which indicates 
all of the arrestin was pre-complexed in an electrostatic interaction with the 
phosphorylated receptor C-terminus. Upon light-activation, the arrestin transitions to the 
high-affinity complex with the receptor. As the stoichiometry is unchanged, it suggests 
that arrestin binds the same receptor in the high-affinity complex that it was pre-
complexed to in the dark. 
In the presence of 300mM NaCl the final binding stoichiometry shifts 
In the presence of 300mM NaCl, a different effect emerges. It is clear from the data that 
the addition of salt abrogates formation of the pre-complex, as no binding of arrestin 
occurs to dark state RhP in the presence of 300mM NaCl (graphs b and d, red circles). 
This confirms that 300mM NaCl is sufficient to abrogate this interaction, but still allows 
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for the high-affinity interaction between arrestin and Rh*P, as all of the arrestin was able 
to be pulled down in with an excess of receptor (graph c, red circles). However, the 
stoichiometry of the high-affinity complex in the presence of 300mM NaCl is different 
to that observed in no salt conditions, saturating at a binding stoichiometry of one arrestin 
to 1.5 receptor molecules (determined by the arrestin titrations), which indicates a mixture 
of one-to-one and one-to-two stoichiometries in the sample (see table 3.3.1). Therefore, 
pre-complex formation influences the final binding stoichiometry of the high-affinity 
complex.  
 
3.3.4 Fluorescence changes occurring at sites on arrestin in conditions favouring 
different binding stoichiometries 
In order to further probe the binding of arrestin to rhodopsin in the both the dark state pre-
complex and the high-affinity complex, fluorescence changes at different sites on arrestin 
were monitored, as a function of receptor concentration, at the two different salt 
conditions (low salt, and 300mM NaCl) in the dark and after light-activation. As a control 
the actual amount of arrestin bound to the membranes was determined by centrifugal pull-
down analysis. The arrestin mutants employed were I72NBD (probe located on the finger 
loop) and S344NBD (probe located on the 344-loop on the C-edge). These sites 
demonstrate an increase in fluorescence upon high-affinity binding to Rh*P (Sommer, 
Hofmann et al. 2012), and are accompanied by wavelength shifts in the emission spectra, 
indicative of movement of the fluorophore into a more hydrophobic environment (see 
section 2.1). At site 72 this is as a result of interaction with the active receptor crevice 
(Sommer, Smith et al. 2005, Hanson, Francis et al. 2006, Szczepek, Beyriere et al. 2014) 
and at site 344 this is due to association with the membrane (see section 3.1).   
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Figure 3.3.3 Centrifugal pull down assays, (black circles), in combination with 
fluorescence measurements (white circles), with 4µM of two different arrestin mutants: 
I72NBD and S344NBD. Receptor titrations were carried out in order to see how the fluorescence 
changes at each of the sites as compared to the total amount of arrestin bound to the receptor in 
4 different conditions: dark state binding to RhP in low salt, dark state binding to RhP with 
300mM NaCl, light-activated binding to Rho*P in low salt, light-activated binding to Rh*P with 
300mM NaCl.  
 
By combining the fluorescence data with the binding data from the centrifugal pull-down 
experiments information about engagement of the different sites on arrestin can be 
obtained. In the presence of 300mM NaCl binding of the mutants to dark state RhP was 
abrogated, and there was no change in fluorescence, indicating that no pre-complex 
interaction was occurring. The fluorophore at site 72 showed minimal fluorescence 
Centrifugal pull-down 
assay 
Fluorescence assay 
  
  
[Receptor] (µM) [Receptor] (µM) 
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change when bound to RhP in the pre-complex in the absence of NaCl, even though 
arrestin was bound. Conversely after light-activation the fluorescence increase reported 
the amount of arrestin bound, in both low salt conditions and with 300mM NaCl. This is 
consistent with this site binding in the crevice of the active receptor. The fluorophore at 
site 344 similarly only showed a small fluorescence increase when bound in the pre-
complex to RhP in the absence of NaCl, but reports the amount of arrestin bound in the 
high-affinity complex to Rh*P in the absence of NaCl. This site has been shown to 
associate with the membrane in both the pre-complex and the high-affinity complex (see 
section 3.1). However, the depth of membrane association is different. In the high-affinity 
complex it penetrates the membrane interior, which is consistent with a fluorescence 
increase due to a hydrophobic environment. In the pre-complex, however, it is located at 
the membrane surface, which correlates with a lower fluorescence intensity (see section 
3.2.3). When bound to Rh*P in the high-affinity complex in the presence of 300mM 
NaCl, the fluorescence signal saturates at a lower receptor concentration, as compared to 
arrestin binding. This indicates that this site is in a different environment when arrestin is 
bound in a one-to-one or a one-to-two stoichiometry.  
 
3.3.5 Can the 344-loop contact a second receptor? 
The 344-loop of the C-edge of arrestin was shown to act as a membrane anchor in both 
the pre-complex and the high-affinity complex (see section 3.1). However, the model 
proposed by Sommer et al. (Sommer, Hofmann et al. 2012), suggested that when arrestin 
was bound to rhodopsin in a one-to-two stoichiometry, this loop could interact with a 
second receptor. In order to investigate this hypothesis further, fluorescence quenching 
experiments using spin-labelled fatty acids were carried out, as described in section 3.1, 
in the presence of 300mM NaCl, which favours a binding stoichiometry of between one-
to-one and one-to-two.  
Briefly, the experiment followed the fluorescence of fluorescently-labelled arrestin in the 
presence of rod outer segment (ROS) membranes containing rhodopsin, that were 
enriched with spin-labelled fatty acids which insert spontaneously into the membrane and 
are able to quench fluorescence. The fatty acid N-tempoyl-palmitamide reported on 
association with the membrane surface, and the fatty acid 5-doxyl-stearic acid reported 
on association within the membrane interior. Experiments were carried out with dark state 
(RhP) and light-activated (Rh*P) phosphorylated rhodopsin.    
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The C-edge of arrestin interacts with the membrane in the presence of 300mM NaCl 
Very little quenching was observed in the dark state, due to the low amount of arrestin 
binding to dark state phosphorylated rhodopsin (RhP) in the presence of 300mM NaCl. 
However, after light-induced arrestin binding, quenching was observed at all sites on the 
344-loop (L342B, S344B and L339B) and 197-loop (F197B), by both N-tempoyl 
palmitamide and 5-doxyl stearic acid, indicative of arrestin interacting with the membrane 
(see figure 3.3.4). Moreover, the quenching pattern was similar to that observed at sites 
on these loops in buffer containing low salt. This demonstrates that the 344-loop and the 
197-loop both penetrate the membrane, and are accessible to quenchers at the membrane 
surface and in the hydrophobic interior in conditions favouring a one-to-one 
stoichiometry as well as conditions in which a one-to-two binding stoichiometry occurs.  
Fluorophores attached to sites on the N-domain of arrestin (I72B and V159B), also 
showed a similar quenching pattern in the presence of 300mM NaCl as compared to low 
salt buffer, with quenching of the fluorophore at site 72 observed by N-tempoyl 
palmitamide at the membrane surface. Site 159 serves as a negative control as it showed 
very little quenching by either N-tempoyl-palmitamide or 5-doxyl stearic acid, in both 
Wavelength (nm) Wavelength (nm) 
Wavelength (nm) Wavelength (nm) 
Figure 3.3.4 Steady-state 
fluorescence spectra of 
fluorescently-labelled arrestin 
mutants in low salt buffer and 
buffer with 300mM NaCl, bound to 
Rh*P 
Black= 1µM arrestin + 4µM ROS, green 
= 1µM arrestin + 4µM ROS enriched 
with N-tempoyl palmitamide, blue = 1µM 
arrestin + 4µM ROS enriched with 5-
doxyl stearic acid 
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low salt or 300mM NaCl buffers. This demonstrates that the quenching observed on the 
C-edge loops in the presence of 300mM NaCl is due to specific penetration of the 
membrane by these loops, when arrestin is bound to Rh*P.  
3.3.6 Conclusions 
Experiments presented in this section indicate that one-to-one and one-to-two binding 
stoichiometries of arrestin-to-Rh*P are both possible in native rod outer segment 
membranes. The clear observation of one-to-one binding indicates that space on the ROS 
membrane is not limited with respect to arrestin binding. Furthermore, there is a 
correlation between the stoichiometry of the high-affinity complex and the formation of 
the pre-complex. The stoichiometry of the high-affinity complex shifts to a mixture of 
one-to-one and one-to-two, in concentrations of salt which abrogate formation of the pre-
complex.  
The fluorophore at site 72 always reports the amount of arrestin bound in the high-affinity 
complex, but not in the pre-complex, indicative of engagement with the active receptor 
crevice. Similarly, the fluorophore at site 344 reported an increase in fluorescence when 
bound in the high affinity complex as compared to the pre-complex, which correlates to 
movement of this site into the hydrophobic membrane interior in the high affinity 
complex. However, the fluorescence at this site was sensitive to the stoichiometry of the 
interaction. The model proposed by Sommer et al. 2012 suggested that in the one-to-two 
binding stoichiometry the 344-loop could contact a neighbouring receptor. However, 
fluorescence quenching experiments using spin-labelled fatty acids presented in this 
section report membrane anchoring of this loop in the presence of 300mM NaCl, which 
favours a higher stoichiometry. As this loop serves as a membrane anchor in conditions 
with both one-to-one and one-to-two arrestin binding stoichiometries, it does not play a 
role in interacting with the second receptor. It remains unclear why the fluorescence of 
the fluorophore at site 344 does not report on the amount of arrestin bound in the presence 
of 300mM NaCl, even though the loop is associating within the membrane interior. One 
possible explanation is that the fluorescence is being quenched by a component in the 
membrane, for example the phospho-head groups of the phospholipids, and that this effect 
is increased in the presence of salt. Another possibility is that either the angle or the 
flexibility of the loop is different in the presence of 300mM NaCl as compared to in the 
absence of salt, and so even though the loop remains accessible to the quencher groups 
on the fatty acids, the fluorescence signal is reduced.  
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A model can therefore be proposed to explain the effect of pre-complex formation upon 
the final arrestin-rhodopsin stoichiometry in the high-affinity complex. When arrestin is 
pre-complexed to RhP in the dark, it transitions into the high-affinity complex upon light-
activation, remaining bound to the same receptor. However, in conditions that abrogate 
the pre-complex, arrestin is free in solution. Upon light-activation, it binds Rh*P in the 
high-affinity complex but is able to contact a second receptor, in an irreversible 
interaction, thereby blocking interaction of the second receptor with another arrestin 
molecule. As the C-edge of arrestin always functions as a membrane anchor, irrespective 
of the binding stoichiometry, this secondary interaction site must be with another region 
on arrestin. Other possible candidates are either the N-edge of arrestin, or the arrestin C-
tail. Both of these ideas will be discussed further in the discussion chapter, in section 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
106 
 
4. Discussion 
This dissertation presents results regarding arrestin-rhodopsin interactions, in particular 
the structural and functional characterization of the different binding modes of arrestin. 
These binding modes are dependent on the phosphorylation and activation state of the 
receptor, and represent intermediate states on the path to binding to the receptor in a high-
affinity complex. Arrestin is initially able to interact with the phosphorylated receptor in 
a primarily electrostatic interaction, termed the pre-complex. This pre-complex involves 
interaction of the phosphorylated receptor C-terminus with basic residues within the N-
domain of arrestin, and is a low affinity and dynamic complex. After formation of the 
pre-complex, the interaction between arrestin and rhodopsin transitions into a high-
affinity complex. Arrestin undergoes several conformational changes, involving 
displacement of the C-tail, and an interdomain rotation, resulting in re-orientation of the 
flexible binding loops, which allows for tight binding to the crevice of the active receptor.  
 
RhP + Arr        [Rh*P ~ Arr]pre-complex                          [R*P – Arr]high-affinity 
complex 
 
Scheme 4.1 Scheme of arrestin binding to rhodopsin. The first step is a pre-complex interaction, 
which primes arrestin for transition to tight binding to the receptor in a high-affinity complex. 
 
This work utilised site directed fluorescence in order to monitor the conformational 
changes occurring in arrestin when bound to rhodopsin. A previously unidentified 
interaction of arrestin with the membrane was determined, and the orientation of this 
functional binding element, along with the monitoring of the movement of flexible loops 
on arrestin as it binds different forms of the receptor, have provided insights into the 
structure of the pre-complex as compared to the high-affinity complex. This section will 
discuss the interpretation of these results and their functional implications for arrestin-1 
and other members of the arrestin family.  
 
4.1 Membrane anchoring by arrestin 
The interaction observed between the C-edge of arrestin and the membrane, led to the 
characterization of a previously unidentified binding element on arrestin. Interestingly 
this C-edge membrane anchor is sensitive to the activation state of the receptor, and was 
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deployed differently in the pre-complex as compared to the high-affinity complex. In the 
pre-complex the membrane anchor involves just the 344-loop, and is orientated such that 
the hydrophobic residues penetrate the membrane interior. In the high-affinity complex, 
the orientation of the 344-loop changes. Residues adjacent to the hydrophobic patch 
penetrate the membrane, and additionally the 197-loop embeds within the membrane. 
Mutation of residues on the 344-loop and 197-loop to alanine, have previously been 
shown to reduce binding of arrestin to light-activated phosphorylated rhodopsin (Rh*P) 
(Ostermaier, Peterhans et al. 2014), and there was no association with the membrane 
observed in the absence of receptor, suggesting that engagement of these loops with the 
membrane is a functionally relevant interaction. The function of the membrane anchor 
most likely serves to stabilize the arrestin-rhodopsin interaction, and in particular 
orientates arrestin in the pre-complex to facilitate fast transition to the high-affinity 
complex.  Interestingly, both G proteins and GRKs, have also been seen to engage the 
membrane. In the rod cell, transducin, PDE and GRK1 all contain lipid modifications 
which anchor them to the ROS membrane. Therefore, the theme of membrane anchoring 
among GPCR-binding proteins is a frequent one.  
The mechanism of membrane anchoring by the C-edge of arrestin possibly involves 
interaction with acidic phospholipids. It has previously been determined that arrestin 
binding to Rh*P solubilised in detergent is significantly reduced. However, addition of 
acidic phospholipids restored binding to a level comparable to that observed with native 
ROS membranes (Sommer, Smith et al. 2006). Furthermore, upon light-activation acidic 
phospholipids in the ROS membrane have been shown to flip to the outer membrane 
(Hessel, Muller et al. 2001). The surface of the β-sheet on the C-domain of arrestin 
contains a cluster of basic residues (K232, K235, K236, K238, K257, K267, K332 and 
K330). Therefore it can be speculated that the increased negative charge on the membrane 
surface induced by rhodopsin activation could initially act to electrostatically attract the 
C-domain of arrestin to the membrane.  
In terms of the evolution of arrestin, membrane interaction is a common theme. The 
arrestin clan is made up of the alpha family, the visual/beta family, and the Vsp26 family. 
The alpha arrestins and the Vps26 proteins are more evolutionarily distant, and therefore 
have little sequence similarity with rod arrestin. However, the alpha arrestins are 
membrane-associated proteins with roles in endocytic trafficking, and the Vps26 family, 
which have a similar fold to the visual/beta arrestins, form part of a rotamer complex 
involved in protein trafficking. Even though these members of the arrestin clan are able 
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to associate with the membrane, it is likely that the mechanism of membrane anchoring 
is different from that observed with the hydrophobic 344-loop of arrestin-1. Some alpha 
arrestins in fungi, for example, have been found to contain a C2 membrane binding 
subunit, which binds the membrane through an intermediate Ca2+ ion (Aubry and Klein 
2013). 
Among the visual/beta arrestin family, there is a higher homology, in terms of sequence 
and structure. The 344-loop identified as the main membrane anchor in arrestin-1, is 
conserved in both the visual arrestins, as well as the long variant of arrestin-2 (β-arrestin-
1). The β-arrestins have other functions apart from deactivation of GPCR signalling, such 
as protein scaffolding, and clathrin binding which mediates endocytosis. It is possible 
these processes could be facilitated by the presence of a membrane anchor. The 344-loop 
of the long variant of arrestin-2 has been observed by x-ray crystallography to bind 
clathrin (Kang, Kern et al. 2009, Kern, Kang et al. 2009). This is not the primary clathrin 
binding site, which is located in the region linking the C-tail to the C-domain, but 
mutagenesis studies showed that it is nonetheless functional. In this structure the 
conformation of the 344-loop is similar to that observed in the p44 structure of arrestin, 
indicating that this conformation facilitates clathrin association to arrestin-2 in a similar 
way as membrane association of arrestin-1. Even though association with the membrane 
and clathrin binding are mutually exclusive processes, it is conceivable that the additional 
role of a clathrin binding loop as a membrane anchor could be conducive to endocytosis.  
The short variant of arrestin-2, and arrestin-3 both lack the 344-loop (Zhan, Gimenez et 
al. 2011).  However, both splice variants of arrestin-2 have been shown to interact in a 
similar way with β2-adrenergic and M2-muscarinic cholinergic receptors (Gurevich, 
Dion et al. 1995), suggesting that the presence of the 344-loop is not necessary for GPCR 
binding. It is possible that the 197-loop, which is conserved among all arrestins, and was 
observed to penetrate the membrane in the high-affinity complex, is sufficient for 
membrane anchoring in the absence of the 344-loop.  
  
4.2 Structure of the pre-complex 
The pre-complex represents an intermediate binding step in the arrestin Rh*P interaction, 
involving a primarily electrostatic interaction with the phosphorylated receptor C-
terminus. The conformation of arrestin in the pre-complex is not well characterised in the 
literature. This dissertation provided some more insights into the structural features of 
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arrestin interaction with receptor phosphates, as well as identifying a secondary 
interaction site, with the membrane. It had previously been proposed that the C-tail was 
displaced upon binding to receptor phosphates or polyanions like heparin or IP6 
(Palczewski, Buczylko et al. 1991, Palczewski, Pulvermüller et al. 1991, Palczewski, 
Pulvermüller et al. 1991). The results presented in this dissertation, however, which 
monitored conformational changes at sites on arrestin when bound to IP6 or 
phosphorylated opsin (OpsP), found that in the absence of the active receptor 
conformation, only the distal portion of the C-tail was displaced. The proximal C-tail 
makes several contacts with the N-domain of arrestin, including the polar core and three 
element interaction, which stabilise arrestin in a basal conformation. As this was not 
displaced by IP6, it indicated that the structure of arrestin in the pre-complex resembles 
the basal conformation. Further experiments which monitored the position of the gate 
loop of arrestin supported this proposal. In the active arrestin structure disruption of the 
polar core results in a significant movement of the gate loop towards the N-domain (Kim, 
Hofmann et al. 2013). However, arrestin interaction with neither IP6 nor OpsP was 
observed to induce this effect. Similarly no interdomain rotation was observed in the 
absence of the active receptor. Recent studies which mutated every site on arrestin 
individually to alanine, and measured binding to Rh*P (Ostermaier, Peterhans et al. 2014) 
and OpsP (Peterhans, Lally et al. 2016), found differences in the proposed arrestin 
phospho-sensing sites. The region of arrestin observed to interact with phosphate groups 
in the crystal structure of arrestin-2 in complex with a phosphopeptide derived from the 
vasopressin receptor (Shukla, Manglik et al. 2013) is a cluster of positively charged 
residues within the N-domain, which are exposed in the active arrestin conformation. 
Mutation of these residues to alanine was found to decrease binding to Rh*P but not to 
OpsP. Arrestin binding to OpsP, however, was decreased by mutation of positively 
charged residues lining the cup of the N-domain (Peterhans, Lally et al. 2016). As these 
residues are exposed in the basal structure of arrestin, it is possible that this is the site of 
interaction of arrestin with the receptor C-terminus in the pre-complex.  
The secondary interaction site of arrestin in the pre-complex, which was identified in this 
dissertation, was membrane anchoring by the arrestin C-edge. In the “open” conformation 
of the crystal structure of basal arrestin-1 (pdb: 1CF1, conformers a and c), the 344-loop 
adopts an extended conformation which exposes the hydrophobic side chains. Membrane 
insertion of this loop conformation would be consistent with results from fluorescence 
quenching experiments, which suggested relative deep insertion of the hydrophobic 
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residues on the 344-loop. Similarly, the lack of interdomain rotation and orientation of 
the 197-loop in the basal arrestin-1 structure would be expected to prevent interaction of 
this loop with the membrane, which is consistent with fluorescence experiments.  Hence, 
the “open” conformation of basal arrestin-1 correlates well to the orientation of the 
membrane anchor observed experimentally, and is further evidence that arrestin remains 
in a basal conformation when bound in the pre-complex.  
 
4.3 Function of the pre-complex 
The pre-complex acts as a dynamic interaction between arrestin and the phosphorylated 
receptor which primes arrestin for tight binding in the high-affinity complex.  In the pre-
complex arrestin is brought into close contact with the receptor, which allows both 
proteins to sense the other’s conformational equilibrium. This facilitates for a fast 
transition to the high-affinity complex, in which the active conformation of both arrestin 
and rhodopsin are stabilised.  
After release of all-trans-retinal from the receptor, opsin exists in a conformational 
equilibrium between Ops (with a conformation similar to that of the inactive receptor), 
and Ops* (with a conformation similar to that of the active receptor). At physiological 
conditions, the inactive Ops conformation is favoured (Vogel and Siebert 2001), but 
arrestin has been shown to stabilise the active Ops* conformation. All-trans-retinal is 
only able to re-enter the binding pocket of the active Ops* conformation (Schafer, Fay et 
al. 2016), and experiments following re-uptake of ATR by opsin found that the percentage 
of OpsP that could bind ATR was increased in the presence of arrestin (50%, compared 
to just 10% in the absence of arrestin) (Sommer, Hofmann et al. 2012). These studies 
indicate that arrestin binding is able to stabilise the otherwise transitory active 
conformation in the receptor. As arrestin binds Ops* with high affinity, this stabilisation 
of Ops* does not result in further signalling as transducin remains occluded from the 
binding site. However, the retinal binding pocket is accessible in the arrestin-bound Ops* 
conformation, to allow for re-entry by ATR.  This has physiological implications as ATR 
is toxic to the rod cell. Therefore, under bright light conditions, when a large 
concentration of ATR is released from Rh*P, the ability of arrestin to stabilise the Ops* 
conformation, allowing for ATR re-uptake, acts as a protective mechanism (Sommer, 
Hofmann et al. 2014).  
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As both arrestin and the receptor are able to sample different conformations in a structural 
equilibrium, it is likely that the structure of the pre-complex displays some heterogeneity. 
As the interaction occurs at two sites, it is possible that different orientations exist where 
both sites are not engaged simultaneously. A recent EM structure of the arrestin-receptor 
complex visualized two different orientations of arrestin binding to the receptor (Shukla, 
Westfield et al. 2014). In the first orientation arrestin was interacting with the helical core 
of the receptor, and is likely to represent the high-affinity complex. However, in the 
second structure, arrestin was “hanging off” from the receptor, at a 90° angle to the 
membrane. The structure obtained was a visualisation of the complex in a detergent 
micelle, and so no membrane was present. It is therefore possible that this represents an 
orientation of arrestin in the pre-complex, bound only by the interaction between the N-
domain of arrestin and the phosphorylated receptor C-terminus. Heterogeneity in 
engagement of both interaction sites in the pre-complex could also explain recent FTIR 
experiments, which monitored the kinetics of transition of arrestin from the pre-complex 
to the high-affinity complex. In this study, two rate constants were measured: a fast and 
a slow component (Beyriere, Sommer et al. 2015). It is possible that the fast component 
measured represents arrestin pre-complexed with both interaction sites engaged. In the 
absence of one of the two interactions, arrestin would be bound in a more flexible 
orientation, similar to that observed in the EM structure described above (Shukla, 
Westfield et al. 2014), which could result in the slow component observed.  
Apart from facilitating fast binding upon receptor activation, the pre-complex could have 
other functions, particularly in other GPCR systems. Recently an EM structure of a 
“supercomplex” was visualized (Thomsen, Plouffe et al. 2016) which showed a GPCR in 
complex with both β-arrestin and a G protein, which allows for continued signalling from 
GPCRs internalized in endosomes. In the structure the G protein was bound to the helical 
core of the receptor, with arrestin bound adjacent to the G protein. Arrestin was not 
engaged by the receptor binding crevice, and interestingly the C-edge of arrestin was 
positioned in such a way as to suggest interaction with the membrane. It is therefore 
possible that the structure represents an orientation similar to that of the pre-complex. 
This interaction would therefore have further implications beyond fast GPCR signal shut-
off, and may be implicated in arrestin-mediated signalling.    
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4.4 The high-affinity complex 
Site directed fluorescence measurements carried out in this dissertation, which monitored 
the position of different sites on arrestin when bound to Rh*P or Ops*P provided 
information about the conformational changes occurring in arrestin when bound in the 
high-affinity complex as compared to the pre-complex. Interaction with the 
phosphorylated, active receptor results in the release of the distal and proximal portions 
of the arrestin C-tail. Full C-tail displacement results in the fully active conformation of 
arrestin, in which the polar core is broken due to gate loop movement, the finger loop is 
freed for receptor interaction, and the domains of arrestin are rotated against one another, 
as shown in chapter 3.2. These conformational hallmarks of arrestin activation are seen 
in the crystal structures of  p44, arrestin-2 bound to a phosphopeptide analogue of the 
phosphorylated receptor C-terminus, and the Ops*/arrestin-1 fusion complex (Kim, 
Hofmann et al. 2013, Shukla, Manglik et al. 2013, Kang, Zhou et al. 2015). 
A change in the orientation of the membrane anchor was also observed during transition 
from the pre-complex to the high-affinity complex. The C-edge conformation and 
orientation suggested by fluorescence experiments correlated well with molecular 
dynamics simulations of the C-edge of p44 with the membrane (see chapter 3.1).  In this 
conformation the hydrophobic residues that were observed to penetrate the membrane in 
the pre-complex insert more shallowly with the membrane, and the residues adjacent to 
the hydrophobic cluster are also seen to interact with the membrane interior. The 197-
loop, which does not associate with the membrane in the pre-complex, penetrates the 
membrane interior in the high-affinity complex. Overlay of the simulated C-edge of p44 
with the crystal structure of the Ops*/arrestin-1 fusion complex in the hypothetical 
membrane plane (Kang, Zhou et al. 2015), found that the orientation of arrestin in the 
crystal structure is consistent with that predicted by the simulations and the fluorescence 
experiments for the high-affinity complex.  
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Figure 4.1 Model of arrestin binding to rhodopsin 
The N-domain of arrestin is shown in blue, and the C-domain is shown in green. In the basal 
state of arrestin the C-tail (shown in red) makes several contacts with the N-domain, and the 
finger loop is folded down. In the pre-complex interaction the distal part of the C-tail is 
displaced (shown in red, dashed line) but the proximal portion remains in contact with the N-
domain (red, solid line). The phosphorylated receptor C-terminus interacts with the concave 
surface of the N-domain (denoted by purple spheres with the letter p), and the 344-loop of the 
C-edge is penetrating the membrane. After light-activation the receptor adopts an active 
conformation, and the high-affinity complex forms. In this conformation, the C-tail is completely 
displaced, the polar core is disrupted, the finger loop is extended and binds into the open 
receptor crevice, and there is an interdomain rotation. The C-edge penetrates the membrane 
through both the 344- and 197-loops, and the receptor phosphates bind within the N-domain. 
Figure adapted from Martha Sommer, poster. 
 
 
The stoichiometry of the high-affinity complex was observed to be dependent on 
formation of the pre-complex; robust pre-complex formation favoured a one-to-one 
arrestin-to-Rh*P binding stoichiometry, while dissolution of the pre-complex with 
moderate salt concentrations favoured a mixture of one-to-one and one-to-two binding 
stoichiometries (see chapter 3.3). The membrane anchor was shown to be engaged in both 
the one-to-one and one-to-two complex, which rules out the previously proposed 
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hypothesis that the 344-loop on arrestin could contact a second receptor (Sommer, 
Hofmann et al. 2012). The exact nature of the one-to-two arrestin-rhodopsin complex 
therefore, remains unclear. Fluorescence studies with the finger loop on arrestin, indicate 
that this loop is always embedded within the receptor crevice in both the one-to-one and 
one-to-two complex. It is possible that in the one-to-two complex, the neighbouring 
receptor is contacted by the N-domain of arrestin. The 160-loop in particular contains 
many negatively charged residues, which could be involved in an electrostatic interaction 
with the positively charged cytoplasmic surface of the receptor. In the crystal structure of 
the Ops*‒arrestin-1 fusion complex, the 160-loop folds back to contact the cytoplasmic 
portion of helix 6 of the receptor (Kang, Zhou et al. 2015). However, the fluorescence 
quenching experiments presented in this dissertation suggest the 160-loop can interact 
with the membrane surface (see chapter 3.1). As the 160-loop is flexible it can likely 
adopt many different conformations, which could allow it to access a second receptor. 
Another possible interaction site is the displaced arrestin C-tail. This also has a cluster of 
negatively charged residues, which could be form an electrostatic interaction with the 
surface of the second receptor. Importantly these interactions need not bind deep into the 
receptor binding crevice in the same manner as the finger loop in order to be sufficient to 
block further binding of arrestin. Many studies have proposed that GPCRs are able to 
form dimers or higher oligomers. Rhodopsin was initially crystallised as a dimer, and 
atomic force microscopy has shown that higher-order oligomers are also likely to occur 
in the rod cell (Fotiadis, Liang et al. 2003, Liang, Fotiadis et al. 2003).  It has been 
proposed that the organisation of GPCRs into asymmetric oligomeric clusters, allows for 
the receptor to be stabilised in distinct conformations, resulting in differential modulation 
of ligand binding (Maurice, Kamal et al. 2011). It is also conceivable that binding of 
interaction partners, such as arrestin, to the receptor could induce or stabilise oligomer 
formation. When arrestin is not already pre-complexed, it would then be able to contact 
the second receptor, either through interaction of the 160-loop, the C-tail, or a further 
binding element, to occlude any further arrestin binding. In contrast, when arrestin is pre-
complexed in the dark, transition to the high-affinity complex occurs fast, with each 
arrestin binding to the active receptor crevice, before any interaction with a second 
receptor can occur.    
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4.5 Conclusions and future directions 
This dissertation reports site directed fluorescence experiments that have furthered our 
knowledge of arrestin-rhodopsin interactions. In particular, a new functional binding 
element of arrestin, the C-edge membrane anchor, was identified. The C-edge membrane 
anchor is activated for membrane engagement only in the presence of phosphorylated 
receptor and is engaged differently when arrestin is bound in the pre-complex as 
compared to the high-affinity complex.  
The distinct conformation of arrestin in the pre-complex as compared to the high-affinity 
complex was investigated further. In the pre-complex arrestin was found to adopt an 
orientation similar to that seen in the “open” conformer in the basal crystal structure, with 
just the distal portion of the C-tail displaced. In this pre-complex there are two interaction 
sites: an electrostatic interaction between the receptor phosphates and the concave surface 
of the N-domain, as well as the 344-loop on the C-edge of arrestin with the membrane. 
Upon light-activation, the conformation of arrestin changes as it transitions to the high-
affinity complex. In this complex arrestin has a conformation similar to that observed in 
the p44 crystal structure. The C-tail is displaced, the polar core and three element 
interaction are disrupted, which results in changes within the central crest loops and a 21° 
rotation. This complex involves interactions between the receptor phosphates and the 
positively-charged cleft, which is exposed within the N-domain in the active arrestin 
structure, the finger loop and the central crest loops of arrestin interact with the helical 
core of the receptor, and the 344-loop and 197-loop on the C-edge of arrestin penetrate 
the membrane.   
In addition, the effect of the pre-complex on the final binding stoichiometry of the high-
affinity complex was investigated. Conditions that abrogated the pre-complex were found 
to result in a higher stoichiometry of arrestin-rhodopsin interaction, whereas in conditions 
allowing for pre-complex formation the stoichiometry suggested that each arrestin 
interacted with one rhodopsin molecule.  
The results presented in this dissertation provide further insights into the arrestin-
rhodopsin complex, which have implications not just within the visual system, but across 
the entire GPCR family. In humans, mutations in arrestin result in a form of night-
blindness, called Oguchi disease, caused by a delay in dark adaptation (Lamb and Pugh 
2004). Even though the experiments presented in this dissertation were carried out with 
bovine arrestin and bovine rhodopsin, they both share a high homology to their human 
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counterparts. As such the insights gained in this dissertation into arrestin binding to 
rhodopsin in the pre-complex and the high-affinity complex, can be applied for studying 
this disease in humans. Importantly, further characterisation of the arrestin-rhodopsin 
complex also has implications with other GPCR systems. In particular, the interaction 
between arrestin and the membrane is likely to occur for all four arrestin members of the 
visual/beta arrestin family. Arrestin-2 and arrestin-3 (β-arrestin-1 and β-arrestin-2) 
interact with hundreds of different GPCRs, and are involved not only with G protein-
mediated signal shut-off, but also facilitate receptor internalisation, and mediate their own 
signalling pathways (Xiao et al. 2007; Lohse and Hoffmann 2015; Reiter et al. 2012). 
Therefore, the discovery of an additional binding element between visual arrestin-1 and 
the membrane, opens a new area of research not only into the role this interaction plays 
in arrestin binding to GPCRs, but also in carrying out its additional cellular functions. 
There are a number of details about the arrestin-receptor interaction, which remain to be 
investigated in the future. This includes the implications of the membrane anchor in 
different GPCR systems, and its possible role in clathrin binding or scaffolding of proteins 
to the membrane. Studies using BRET would be useful for monitoring the interactions 
occurring with the arrestin membrane anchor. Similarly, studies investigating the effect 
of arrestin binding to the receptor in the absence of the 344-loop (as in the case of arresitn-
3 and the short splice variant of arrestin-2) would be interesting in further elucidating the 
functional implications of membrane anchoring in the pre-complex interaction. The 
effects of membrane composition on the arrestin-membrane interaction would also be 
useful for determining the mechanism of binding.  
Further investigation into the structure of the pre-complex, and in particular the 
conformational flexibility and heterogeneity of this interaction, using techniques such as 
double-electron-electron resonance (DEER) or Fourier transform infra-red spectroscopy 
(FTIR) could be utilised to provide more inights into this interaction. Further 
investigation into the implications of pre-complex formation in other GPCR systems, 
such as simultaneous arrestin and G protein mediated signalling would also be an 
interesting area of research.  
More research is also required in order to probe the nature of the one-to-two stoichiometry 
observed in this dissertation. Experiments with p44, which lacks the C-tail, or with 
fluorescence probes on the 160-loop on the arrestin N-domain in combination with 
quenching groups introduced into the rhodopsin binding pocket, would be initial 
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experiments that could be carried out in order to identify if these arrestin elements are 
involved with contacting a second receptor. Further experiments should also be carried 
out to investigate if G-protein binding is effectively inhibited when arrestin is bound to 
two receptors.  
In conclusion, this dissertation has addressed many questions about the arrestin-rhodopsin 
complex, and the conformation of different binding modes of interaction. The findings 
presented in this dissertation also have other implications in different GPCR-systems, 
which can be further investigated.  
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